No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4366 |
4. Check minimum number of eventsNone |
4366 |
5. Include endpointsNone |
4366 |
6. Filter based on genotype QC (FinnGen only) |
4366 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D70-D77
- Name in latin
- Agranulocytosis
Similar endpoints
↥List of similar endpoints to
Agranulocytosis
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26750 | 15948 | 10643 |
| Only index persons | 23160 | 14088 | 9072 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.39 | 0.46 | 0.30 |
| Only index persons | 0.45 | 0.52 | 0.35 |
| Median age at first event (years) | |||
| Whole population | 60.55 | 59.89 | 61.46 |
| Only index persons | 60.52 | 59.67 | 61.85 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4366 | 2748 | 1618 |
| Unadjusted period prevalence (%) | 0.85 | 0.94 | 0.71 |
| Median age at first event (years) | 60.90 | 58.44 | 65.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3963
- Matched controls
- 39628
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
17.4
323.0
804
572
A03FA01
ATC
metoclopramide; systemic, rectal
8.2
323.0
2197
5244
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
13.1
323.0
707
646
R50.9
ICD-10 Finland
Fever, unspecified
7.1
323.0
1477
3047
115
Kela drug reimbursment
Breast cancer
6.8
323.0
956
1760
ZX120
NOMESCO Finland
Intravenous
6.4
323.0
983
1945
L03AA13
ATC
pegfilgrastim; parenteral
19.3
323.0
989
671
JN4BD
NOMESCO Finland
Extensive body CT
7.1
323.0
1206
2300
L03AA02
ATC
filgrastim; parenteral
21.9
323.0
715
394
XW000
NOMESCO Finland
Bone marrow biopsy
20.0
323.0
848
533
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3176.7
323.0
1632
9
A49.9
ICD-10 Finland
Bacterial infection, unspecified
13.2
323.0
1638
2011
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.3
323.0
908
711
A04AA02
ATC
granisetron; systemic, transdermal
12.6
323.0
1111
1185
H02AB02
ATC
dexamethasone; systemic
12.9
323.0
1729
2237
WW500
NOMESCO Finland
Blood transfusion
15.7
323.0
783
613
D70.82
ICD-10 Finland
Drug-induced neutropenia
4503599627370496.0
323.0
2397
*
L03AA14
ATC
lipegfilgrastim; parenteral
19.9
315.7
490
279
A04AA01
ATC
ondansetron; systemic, rectal
7.3
308.2
814
1351
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
306.1
2413
12075
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
17.3
291.9
477
311
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
26.4
286.4
405
170
N02AA05
ATC
oxycodone; systemic
4.8
281.4
1117
3017
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
8.4
278.3
663
930
J01MA12
ATC
levofloxacin; systemic
4.0
260.6
1286
4233
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.3
253.7
1950
9087
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
24.2
237.3
344
155
JN4AD
NOMESCO Finland
Body CT examination
5.8
237.2
745
1516
A04AD12
ATC
aprepitant; systemic
12.9
216.2
399
341
Z51.5
ICD-10 Finland
Palliative care
6.5
203.7
577
1016
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
196.5
1790
8867
A04AA55
ATC
palonosetron, combinations; systemic
9.3
194.4
427
509
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
194.4
817
2238
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
14.6
184.8
321
237
HAC20
NOMESCO Finland
Total mastectomy
7.1
183.1
480
754
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
7.5
180.6
457
681
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
7.4
177.0
452
682
HA1AA
NOMESCO Finland
X-ray mammography
4.7
176.3
673
1662
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.2
174.9
384
455
A41.9
ICD-10 Finland
Sepsis, unspecified
8.3
174.1
408
539
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
19.5
174.0
270
148
L02BG04
ATC
letrozole; oral
5.2
173.9
589
1277
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.9
173.9
390
479
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.0
173.8
615
1400
130
Kela drug reimbursment
Malignant tumour
4.7
171.1
641
1549
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
5.2
164.2
555
1196
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
158.1
859
2888
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.3
157.3
522
1099
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.8
155.4
380
534
L02BA01
ATC
tamoxifen; oral
6.6
155.2
429
719
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
148.0
668
1912
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.2
146.9
499
1075
ZX112
NOMESCO Finland
Subcutaneous
10.0
146.6
306
329
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
138.8
1161
5191
WZC30
NOMESCO Finland
Teaching
3.2
136.2
831
3010
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.7
134.9
208
111
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.5
130.5
362
605
PJA12
NOMESCO Finland
Sentinel node biopsy
3.9
130.2
596
1713
M04AA01
ATC
allopurinol; systemic
3.4
129.9
718
2410
A02BC02
ATC
pantoprazole; systemic
2.3
128.7
2801
20157
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.0
128.2
226
171
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
5.1
124.5
422
900
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
20.9
123.3
186
93
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.9
122.0
429
951
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
121.3
841
3300
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
116.4
1067
4945
L01BC06
ATC
capecitabine; oral
6.1
116.0
338
600
B01AB05
ATC
enoxaparin; parenteral
2.3
112.5
1453
8010
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.0
110.3
480
1308
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.4
109.8
431
1066
B01AB10
ATC
tinzaparin; parenteral
4.0
108.3
483
1344
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.8
108.0
325
600
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
10.1
107.3
221
230
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.2
105.8
269
396
D69.5
ICD-10 Finland
Secondary thrombocytopenia
54.2
105.4
126
24
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
6.9
103.1
270
414
H02AB06
ATC
prednisolone; systemic
2.1
101.2
2023
13318
C50.99
ICD-10 Finland
Breast, unspecified
6.7
99.9
269
429
X76
ICPC
Malignant neoplasm breast female
7.9
97.5
233
312
JN4CD
NOMESCO Finland
Very extensive body CT
5.2
94.7
314
647
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
17.1
94.6
153
93
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
93.9
349
813
JN6AD
NOMESCO Finland
CT of torso and neck
11.2
91.7
178
165
ZX070
NOMESCO Finland
Intensity modified radiotherapy
8.1
90.6
212
274
ZX080
NOMESCO Finland
Image guided radiotherapy
7.3
89.9
226
326
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.5
88.1
449
1387
J01MA14
ATC
moxifloxacin; systemic
3.2
87.3
518
1792
NK6AN
NOMESCO Finland
Total body bone isotope imaging
5.8
85.0
254
462
C83.1
ICD-10 Finland
Mantle cell lymphoma
32.0
84.2
112
36
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
10.3
82.2
167
169
WW300
NOMESCO Finland
Transfer of autologic stem cells
29.7
81.2
110
38
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
47.8
80.3
98
21
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.0
79.9
274
584
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
79.8
995
5225
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
8.7
78.8
176
211
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.2
77.5
167
188
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.5
76.7
136
104
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.5
76.4
238
455
L02BG06
ATC
exemestane; oral
8.6
75.6
170
206
D70.80
ICD-10 Finland
Agranulocytic angina
+∞
75.2
72
*
M05BX04
ATC
denosumab; parenteral
3.9
74.2
329
900
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
74.0
491
1821
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.2
73.3
158
178
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
8.3
73.1
168
211
TGC00
NOMESCO Finland
Bronchial lavation
5.8
72.8
217
393
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.2
71.7
236
480
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
70.7
427
1484
D70.81
ICD-10 Finland
Neutropenia congenital
+∞
70.0
67
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
69.6
336
987
C03CA01
ATC
furosemide; systemic
2.0
69.3
1111
6423
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
26.1
69.3
97
38
ZX108
NOMESCO Finland
Inhalation
15.7
68.0
113
74
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.6
67.5
248
567
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.8
66.5
175
269
J05AB11
ATC
valaciclovir; oral
2.4
66.5
649
2998
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
6.0
66.0
191
333
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
18.2
65.6
103
58
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
65.6
2087
15249
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.4
65.2
178
288
D70
ICD-10 Finland
Agranulocytosis
648.7
65.1
64
*
WF004
NOMESCO Finland
Palliative radiotherapy
6.5
64.6
174
276
J01DB01
ATC
cefalexin; oral
2.0
64.6
3246
27529
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
63.2
1174
7128
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.2
62.9
145
183
L01CB01
ATC
etoposide; systemic
23.6
62.5
90
39
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.5
61.9
191
360
HAB40
NOMESCO Finland
Wedge excision of mammary gland
3.3
61.9
335
1073
PJA10
NOMESCO Finland
Exploration of lymph nodes
8.2
61.9
142
178
1CD02
NOMESCO Finland
NA
10.4
61.7
124
123
Z31.5
ICD-10 Finland
Genetic counselling
3.6
61.4
294
856
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
7.0
60.3
154
227
N02BE01
ATC
paracetamol; systemic, rectal
2.1
60.3
3408
29658
YNB10
NOMESCO Finland
Collection of stem cells for transplant
48.8
59.4
72
15
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
8.8
59.1
130
152
L01CA04
ATC
vinorelbine; systemic
11.5
58.8
112
100
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
22.8
58.5
85
38
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
58.5
908
5128
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
6.8
58.4
153
234
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
57.7
294
898
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
56.5
1199
7566
B03XA02
ATC
darbepoetin alfa; parenteral
6.8
56.3
146
220
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
5.0
56.1
187
385
127
Kela drug reimbursment
Transplant complication
7.3
55.9
138
194
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
55.8
413
1625
128
Kela drug reimbursment
Cancers of female genital organs
5.8
55.8
164
292
N05BA06
ATC
lorazepam; systemic, sublingual
3.5
54.7
274
826
N05CF01
ATC
zopiclone; oral
1.8
54.6
1291
8421
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
7.1
54.4
137
198
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.1
53.8
153
261
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
30.5
53.8
72
24
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
53.4
1478
10117
N05AH03
ATC
olanzapine; systemic
3.2
53.2
300
987
28899
ICD-8 Finland
Agranulocytosis
+∞
52.2
50
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
52.0
1639
11632
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
52.0
505
2305
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
7.7
51.3
122
162
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.9
51.1
132
198
A41.8
ICD-10 Finland
Other specified sepsis
6.6
51.1
135
209
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
4.8
51.0
176
377
A06AD11
ATC
lactulose; oral
2.2
50.9
592
2940
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
10.2
50.7
102
102
1XC02
NOMESCO Finland
NA
9.9
49.9
102
105
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
24.1
49.8
71
30
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
6.5
49.8
134
213
N05AH02
ATC
clozapine; systemic
6.1
49.0
138
233
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.7
48.5
171
374
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
4.8
48.5
170
370
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
48.1
441
1948
SPAT1255
SPAT
Intravenous administration of medicine
2.9
47.7
321
1186
A79
ICPC
Malignancy NOS
7.1
47.6
120
174
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
47.1
507
2426
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
5.9
47.1
137
241
192
Kela drug reimbursment
Fulvestrant
13.7
47.0
82
61
TQW20
NOMESCO Finland
Tatoe
6.6
46.7
123
190
C50
ICD-10 Finland
Malignant neoplasm of breast
4.5
46.4
171
392
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
25.4
46.3
65
26
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
46.1
372
1532
ED1AA
NOMESCO Finland
Mandipular X-ray examination
13.8
46.0
80
59
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
45.2
175
421
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
4.8
44.3
154
332
L02BA03
ATC
fulvestrant; parenteral
12.3
44.3
81
67
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.9
43.9
189
501
ZXD05
NOMESCO Finland
Urgent procedure
1.7
43.9
1197
8036
R4110
NOMESCO Finland
Physiotherapy
1.7
43.5
1059
6869
WF002
NOMESCO Finland
Radical radiotherapy
3.2
43.1
243
797
ZX121
NOMESCO Finland
Central venous catheter
14.6
43.0
73
51
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.4
42.9
409
1841
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
5.8
42.7
124
218
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
42.6
458
2184
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
3.1
41.9
247
837
Z51.0
ICD-10 Finland
Radiotherapy session
6.6
41.3
109
169
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
41.3
579
3094
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
10.1
41.1
83
84
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
41.1
226
730
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.4
41.0
127
241
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
5.0
40.9
135
276
WX402
NOMESCO Finland
General anaesthesia
1.9
40.8
701
4040
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
6.4
40.3
109
175
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
4.2
40.2
161
400
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
39.7
291
1134
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
5.8
39.3
115
204
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
19.0
39.2
60
32
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.9
39.0
259
948
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
5.1
38.9
126
252
1501
Kela drug reimbursment
Palbociclib
11.1
38.5
74
68
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.4
38.5
119
226
L02BG03
ATC
anastrozole; oral
5.0
38.3
127
261
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.6
38.2
91
122
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
35.4
38.1
49
14
C82.1
ICD-10 Finland
Follicular lymphoma grade II
9.6
38.1
79
84
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
38.1
642
3668
A46
ICD-10 Finland
Erysipelas
2.0
38.1
533
2837
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
16.7
38.1
61
37
L04AA06
ATC
mycophenolic acid; systemic
5.1
38.0
124
250
R11
ICD-10 Finland
Nausea and vomiting
2.4
38.0
347
1523
J01MA02
ATC
ciprofloxacin; systemic
1.6
37.9
1439
10461
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
36.9
577
3201
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.8
36.8
126
268
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
7.3
36.7
90
126
ZXE00
NOMESCO Finland
One hour or less
1.6
36.7
1514
11210
Z2446
NOMESCO Finland
Social worker
2.5
36.7
303
1263
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.8
36.7
162
440
FM1FN
NOMESCO Finland
Heart function isotope examination
9.8
36.7
75
78
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
7.0
36.2
91
132
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
4.9
36.2
121
251
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
7.6
36.2
86
115
A06AH03
ATC
naloxegol; oral
7.1
36.1
90
129
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
20.3
36.1
54
27
Z3231
NOMESCO Finland
Registered nurse
1.6
35.9
1068
7263
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
8.0
35.7
82
104
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
14.1
35.6
61
44
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
4.6
35.5
127
283
J05AB01
ATC
aciclovir; systemic
1.7
35.3
821
5201
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.9
35.3
82
106
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
34.8
336
1517
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.7
34.5
244
927
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.5
34.4
125
283
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.6
34.3
269
1089
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
34.2
491
2635
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
8.4
34.1
76
92
A07AA02
ATC
nystatin; oral
2.5
33.9
287
1209
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.5
33.8
75
90
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
21.6
33.5
49
23
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
33.0
365
1754
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
17.0
32.8
52
31
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
12.5
32.2
58
47
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
8.5
32.1
71
85
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
4.5
32.0
117
267
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
29.0
32.0
43
15
A28
ICPC
Limited function/disability NOS
1.9
31.9
523
2945
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
14.4
31.9
54
38
3AA02
NOMESCO Finland
NA
114.3
31.7
34
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.5
31.6
114
257
TPX15
NOMESCO Finland
Removal of vascular injection port
10.5
31.6
62
60
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
31.5
238
941
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
14.5
31.4
53
37
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.8
31.4
80
119
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.0
31.2
102
207
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.9
31.2
132
346
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
31.2
1067
7476
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
28.3
31.1
42
15
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
11.3
30.7
58
52
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.4
30.5
155
472
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
18.3
30.5
47
26
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
4.8
30.4
104
222
394
Kela drug reimbursment
Palbociclib
10.0
30.3
61
62
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
30.3
306
1410
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
13.8
30.3
52
38
N05AD01
ATC
haloperidol; systemic
3.6
30.1
143
413
TGD00
NOMESCO Finland
Needle biopsy of lung
12.1
30.1
55
46
L01XE33
ATC
[U] palbociclib; oral
11.1
30.0
57
52
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.3
29.9
81
131
WW200
NOMESCO Finland
Immunization
3.5
29.8
144
422
SPAT1088
SPAT
Blood transfusion
12.1
29.7
54
45
L04AD01
ATC
ciclosporin; systemic
4.2
29.5
114
275
H02AB09
ATC
hydrocortisone; systemic
3.8
29.3
129
350
ZZF00
NOMESCO Finland
Graft of adipose tissue
6.5
29.3
77
120
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
5.5
29.1
88
164
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
4.5
29.1
106
242
L04AX01
ATC
azathioprine; systemic
2.7
28.8
204
777
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
5.4
28.6
87
163
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
17.8
28.3
44
25
2880B
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, E MEDICAMENTIS]
+∞
28.2
27
*
C90.0
ICD-10 Finland
Multiple myeloma
5.9
28.0
80
139
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
3.8
28.0
122
329
A05AA02
ATC
ursodeoxycholic acid; oral
4.5
27.8
100
225
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
15.0
27.7
46
31
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
42.8
27.7
34
8
ZX131
NOMESCO Finland
Intrathecal
100.8
27.7
30
*
ZY010
NOMESCO Finland
Hospital outpatient
2.6
27.6
207
814
3AA13
NOMESCO Finland
NA
15.7
27.6
45
29
L01BB05
ATC
fludarabine; systemic
28.7
27.6
37
13
N03AX16
ATC
pregabalin; oral
1.6
27.5
875
5984
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
6.1
27.5
76
127
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
27.1
316
1549
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
27.0
1555
12145
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
7.2
27.0
66
93
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
17.7
27.0
42
24
WX110
NOMESCO Finland
Local anesthesy
1.4
26.6
2545
21922
J02AC03
ATC
voriconazole; systemic
24.9
26.5
37
15
N02AX02
ATC
tramadol; systemic, rectal
1.5
26.5
1506
11718
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.9
26.5
88
183
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
26.3
275
1284
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
8.2
26.3
59
73
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
7.5
26.1
62
84
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
26.0
501
2969
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
2.8
25.7
166
599
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
9.6
25.4
52
55
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
6.2
25.4
69
113
R18
ICD-10 Finland
Ascites
4.0
25.4
104
266
WW409
NOMESCO Finland
Other aferesis
14.6
25.1
42
29
HAB99
NOMESCO Finland
Other partial excision of mammary gland
3.3
25.1
132
414
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
15.3
25.0
41
27
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.7
24.9
64
97
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
6.0
24.9
69
116
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.9
24.9
70
120
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
6.4
24.8
66
105
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.8
24.8
167
616
B02.9
ICD-10 Finland
Zoster without complication
2.3
24.8
235
1050
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
24.7
436
2506
L02AE02
ATC
leuprorelin; implant, parenteral
2.7
24.5
170
640
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
24.4
314
1603
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
17.4
24.4
38
22
B72
ICPC
Hodgkin Lymphoma
24.5
24.3
34
14
C91.7
ICD-10 Finland
Other lymphoid leukaemia
48.6
24.3
29
6
J01FF01
ATC
clindamycin; systemic
1.5
24.2
965
6937
A07AA09
ATC
vancomycin; oral
4.9
24.0
80
167
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
9.9
24.0
48
49
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
23.9
223
987
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.7
23.8
107
297
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.6
23.7
180
714
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.5
23.7
85
192
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
23.7
1259
9603
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
5.4
23.5
71
133
188
Kela drug reimbursment
Psychosis requiring demanding treatment
5.4
23.5
71
133
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
7.0
23.4
58
84
C91.4
ICD-10 Finland
Hairy-cell leukaemia
54.3
23.0
27
5
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
12.5
23.0
41
33
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
23.0
119
369
390
Kela drug reimbursment
Ibrutinib
36.5
23.0
29
8
212
Kela drug reimbursment
Gout
4.0
22.9
94
241
N05BA04
ATC
oxazepam; oral
1.5
22.9
885
6298
ZX100
NOMESCO Finland
Oral
4.4
22.9
84
194
1XC03
NOMESCO Finland
NA
9.3
22.7
47
51
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
11.5
22.6
42
37
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
11.5
22.6
42
37
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
22.6
115
353
E0000UV
ATC
NA
1.4
22.5
1408
11057
B34.9
ICD-10 Finland
Viral infection, unspecified
3.2
22.5
120
381
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
22.4
205
897
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
8.2
22.4
50
62
PJW99
NOMESCO Finland
Other operation on lymphatic system
7.6
22.3
52
69
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.1
22.1
87
215
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
22.1
237
1122
SPAT1254
SPAT
Administration of medicine
1.7
22.0
515
3228
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
11.9
22.0
40
34
UJF32
NOMESCO Finland
Coloscopy
1.5
21.9
924
6697
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.6
21.9
99
277
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
29.2
21.8
29
10
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
5.0
21.8
70
141
R06AE07
ATC
cetirizine; oral
1.4
21.8
1572
12654
L01XE27
ATC
[U] ibrutinib; oral
80.6
21.7
24
*
L02AE03
ATC
goserelin; implant
5.1
21.5
68
135
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.5
21.3
76
171
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
21.3
184
784
ZX095
NOMESCO Finland
Combined chemoradiotherapy
6.5
21.3
55
85
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
34.0
21.1
27
8
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
21.1
199
886
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
20.8
632
4236
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
20.8
190
835
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
20.7
246
1218
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
20.6
389
2280
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.3
20.5
77
183
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
20.5
149
577
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
25.6
20.4
28
11
WW402
NOMESCO Finland
Leucoferesis
25.6
20.4
28
11
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.6
20.3
59
106
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.3
20.3
34
24
L01EF01
ATC
palbociclib; oral
12.5
20.3
36
29
R53
ICD-10 Finland
Malaise and fatigue
1.5
20.2
681
4681
JAL30
NOMESCO Finland
Omentectomy
4.3
20.2
75
176
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.7
20.2
89
244
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
20.2
585
3875
1512
Kela drug reimbursment
Ibrutinib
32.7
20.2
26
8
R4190
NOMESCO Finland
Nutritional therapy
2.6
20.1
148
579
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
20.1
135
498
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
9.4
20.0
41
44
163
Kela drug reimbursment
Abiraterone and enzalutamide
5.5
20.0
59
108
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
27.2
20.0
27
10
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
19.9
81
207
L02BB04
ATC
enzalutamide; oral
6.1
19.9
54
89
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
23.5
19.9
28
12
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.1
19.9
233
1146
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
57.8
19.9
23
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
7.8
19.7
45
58
P01AB01
ATC
metronidazole; oral, rectal
1.4
19.7
1411
11281
C83.00
ICD-10 Finland
Lymphocytic lymphoma
13.2
19.7
34
26
B73
ICPC
Leukaemia
29.1
19.6
26
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
19.5
348
2001
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.8
19.5
130
480
5BA08
NOMESCO Finland
NA
7.7
19.5
45
59
6BA02
NOMESCO Finland
NA
13.9
19.5
33
24
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
19.3
156
641
A02BC01
ATC
omeprazole; systemic
1.4
19.1
963
7205
Z3226
NOMESCO Finland
Physiotherapist
1.5
19.1
664
4595
ZXA05
NOMESCO Finland
Left side
1.5
19.0
885
6518
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.2
19.0
203
958
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.7
19.0
54
95
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
19.0
764
5458
TAB00
NOMESCO Finland
Lumbar puncture
2.3
18.9
174
765
HAE99
NOMESCO Finland
Other reconstruction of breast
5.1
18.9
60
120
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
18.9
150
611
A02BC05
ATC
esomeprazole; systemic
1.4
18.9
1438
11592
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
8.8
18.8
40
46
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
11.8
18.7
34
29
ZXA00
NOMESCO Finland
Right side
1.4
18.7
942
7045
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
18.7
1466
11869
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.9
18.7
52
89
B01AB04
ATC
dalteparin; parenteral
2.2
18.6
186
853
J94.8
ICD-10 Finland
Other specified pleural conditions
4.0
18.6
75
191
R50.8
ICD-10 Finland
Other specified fever
6.2
18.6
50
82
N05AF05
ATC
zuclopenthixol; systemic
4.9
18.6
61
127
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
18.5
294
1625
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
6.3
18.5
49
79
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
44.2
18.2
22
5
ZZR10
NOMESCO Finland
Flap of skin and muscle
4.9
18.2
59
121
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
19.4
18.2
27
14
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
6.6
18.1
46
70
AA1AD
NOMESCO Finland
CT of head and brain
1.5
18.1
789
5726
N04AA02
ATC
biperiden; systemic
3.3
18.0
91
280
XX1XN
NOMESCO Finland
Other isotope examination
5.2
18.0
55
106
L01AA01
ATC
cyclophosphamide; systemic
8.7
17.9
38
44
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
17.8
281
4537
WNF00
NOMESCO Finland
Infection source and contact determination
7.9
17.7
40
51
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.7
17.6
125
479
JAH01
NOMESCO Finland
Laparoscopy
2.3
17.6
173
785
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
17.6
491
3212
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
36.9
17.6
22
6
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
9.3
17.6
36
39
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
2.4
17.5
148
626
WX702
NOMESCO Finland
Supraglottic ventilation device
2.1
17.4
208
1032
RS220
NOMESCO Finland
NA
3.9
17.4
72
188
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
17.3
83
245
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
17.3
106
372
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
4.7
17.3
58
124
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.5
17.2
44
68
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
8.5
17.2
37
44
N02AA01
ATC
morphine; systemic, rectal
4.7
17.1
58
125
P01BA02
ATC
hydroxychloroquine; oral
1.8
17.1
313
1814
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.4
17.1
146
621
XX1AD
NOMESCO Finland
Other CT-examination
5.8
17.0
48
84
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
7.1
17.0
41
58
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
31.6
17.0
22
7
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.9
17.0
55
113
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
2.3
16.9
155
680
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
6.0
16.9
46
77
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
19.3
16.8
25
13
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.1
16.8
92
300
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
14.1
16.8
28
20
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
14.1
16.8
28
20
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.3
16.7
86
268
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.4
16.6
145
623
H02AB07
ATC
prednisone; oral
1.6
16.6
495
3294
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
7.7
16.6
38
50
J02AC01
ATC
fluconazole; systemic
1.3
16.5
1435
11747
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
11.6
16.5
30
26
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.8
16.5
55
117
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
2.6
16.5
122
481
TK800
NOMESCO Finland
Hemodialysis
3.1
16.4
92
305
SPAT1263
SPAT
Sampling
1.3
16.4
1477
12154
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.5
16.4
131
537
F20.10
ICD-10 Finland
Raise schizophrenia continuously
9.5
16.4
33
35
S18
ICPC
Laceration/cut
1.3
16.3
1472
12114
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
4.9
16.3
53
110
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.6
16.3
73
205
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
9.2
16.1
33
36
J01CA04
ATC
amoxicillin; systemic
1.4
16.1
2965
27141
L02BX03
ATC
abiraterone; oral
7.0
16.1
39
56
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
47.7
16.0
19
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
13.6
16.0
27
20
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.7
15.9
336
2034
JAH00
NOMESCO Finland
Laparotomy
2.7
15.8
110
419
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
12.9
15.6
27
21
1BC07
NOMESCO Finland
NA
+∞
15.6
15
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.3
15.6
41
66
XX9CD
NOMESCO Finland
Very extensive complementary CT
19.3
15.5
23
12
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
22.1
15.5
22
10
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
22.1
15.5
22
10
D73.1
ICD-10 Finland
Hypersplenism
160.6
15.5
16
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.7
15.3
103
383
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
15.3
58
141
N05AH04
ATC
quetiapine; oral
1.5
15.2
530
3650
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
16.1
15.2
24
15
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
15.2
147
667
N05AX12
ATC
aripiprazole; systemic
2.4
15.1
130
557
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.7
15.0
50
107
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
6.8
14.9
37
55
A03
ICPC
Fever
1.5
14.9
519
3576
SPAT1109
SPAT
Analgesia with portable analgesic pump
6.5
14.9
38
59
Z94.0
ICD-10 Finland
Kidney transplant status
4.3
14.7
54
127
L04AA01
ATC
[U] ciclosporin; systemic
3.3
14.6
74
229
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.9
14.6
60
157
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.9
14.5
87
303
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.4
14.5
69
204
N05AA01
ATC
chlorpromazine; systemic, rectal
3.5
14.5
67
194
122
Kela drug reimbursment
Aplastic anaemia
36.1
14.4
18
5
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
4.9
14.4
46
94
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
4.2
14.4
54
130
L01BC59
ATC
trifluridine, combinations; systemic
12.6
14.4
25
20
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
14.3
523
3642
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
27.3
14.3
19
7
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
27.3
14.3
19
7
L01BB02
ATC
mercaptopurine; oral
5.0
14.2
45
91
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
14.2
553
3899
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
6.3
14.2
37
59
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
9.1
14.2
29
32
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
2.7
14.2
97
367
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
14.1
164
807
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
42.6
14.1
17
*
1CX01
NOMESCO Finland
NA
12.0
14.1
25
21
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
14.0
201
1071
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
14.0
331
2069
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.4
14.0
41
76
HAD99
NOMESCO Finland
Other plastic operation on breast
5.6
14.0
40
72
N05AA02
ATC
levomepromazine; systemic
2.1
14.0
154
741
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.5
14.0
106
423
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
9.4
13.9
28
30
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.8
13.9
87
312
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
13.8
425
2844
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
6.3
13.8
36
58
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.4
13.7
65
192
GEA00
NOMESCO Finland
Mediastinoscopy
6.7
13.7
34
51
X21
ICPC
Breast sympt/compl female other
2.9
13.6
81
281
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
13.6
245
1413
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.2
13.6
51
123
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
7.6
13.6
31
41
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
5.2
13.6
41
79
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.0
13.6
53
133
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.2
13.5
51
124
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
13.4
527
3725
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
6.5
13.3
34
53
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
21.2
13.3
19
9
R84
ICPC
Malignant neoplasm bronchus/lung
7.0
13.3
32
46
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
5.9
13.3
36
61
N05AN01
ATC
lithium; oral
2.6
13.3
95
369
TJA10
NOMESCO Finland
Laparocentesis
9.1
13.2
27
30
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
7.5
13.1
30
40
N06AX16
ATC
venlafaxine; oral
1.5
13.1
460
3172
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.0
13.1
51
128
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
4.0
13.1
51
128
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
12.2
13.1
23
19
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
7.9
13.1
29
37
N03AG01
ATC
valproic acid; systemic, rectal
1.8
13.0
210
1167
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.6
13.0
94
368
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.5
13.0
59
169
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
13.0
126
573
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
28.4
12.9
17
6
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
13.0
12.9
22
17
P72
ICPC
Schizophrenia
3.1
12.9
71
235
N05AX08
ATC
risperidone; systemic
1.8
12.9
231
1333
NF3AA
NOMESCO Finland
Femur X-ray examination
3.0
12.8
71
236
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
12.8
573
4156
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.6
12.8
56
156
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
12.7
137
652
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
14.1
12.7
21
15
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
4.5
12.7
44
99
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
12.7
1299
10786
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
5.4
12.7
37
69
A29
ICPC
General symptom/complaint other
1.6
12.6
360
2363
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.6
12.6
91
355
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
12.6
401
2701
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
12.6
145
709
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
4.3
12.6
46
109
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
7.8
12.6
28
36
JAL00
NOMESCO Finland
Biopsy of peritoneum
5.2
12.5
38
74
R06.0
ICD-10 Finland
Dyspnoea
1.4
12.5
808
6252
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
5.7
12.5
35
62
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
17.3
12.5
19
11
L01AA02
ATC
chlorambucil; oral
8.7
12.5
26
30
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.4
12.5
59
175
1AA09
NOMESCO Finland
NA
20.1
12.4
18
9
SPAT1153
SPAT
Removal of sutures
1.3
12.4
1102
8959
JFF10
NOMESCO Finland
Loop enterostomy
5.6
12.3
35
63
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
3.3
12.3
60
182
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
11.6
12.3
22
19
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
11.6
12.3
22
19
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.8
12.3
76
270
B03BA03
ATC
hydroxocobalamin; parenteral
1.9
12.3
177
948
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
37.6
12.2
15
*
N05AL05
ATC
amisulpride; oral
37.6
12.2
15
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.2
12.2
126
591
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
7.8
12.1
27
35
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.1
12.0
46
114
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
4.8
12.0
39
82
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.5
12.0
41
91
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
11.1
12.0
22
20
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.6
12.0
40
87
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
6.8
11.9
29
43
TQW99
NOMESCO Finland
Other minor procedure on skin
1.9
11.8
167
888
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
4.7
11.8
39
84
WX892
NOMESCO Finland
Monitored bed care
1.7
11.8
247
1495
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
9.6
11.7
23
24
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
3.0
11.7
67
227
J45
ICD-10 Finland
Asthma
0.5
11.6
118
2144
JFB00
NOMESCO Finland
Partial resection of small intestine
3.1
11.6
63
207
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
30.1
11.6
15
5
E89.4
ICD-10 Finland
Postprocedural ovarian failure
30.1
11.6
15
5
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.5
11.6
88
353
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
6.0
11.6
31
52
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
11.5
240
1450
Z94.2
ICD-10 Finland
Lung transplant status
11.1
11.5
21
19
SPAT1229
SPAT
Assessment of need for aid
1.7
11.5
256
1577
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
2.5
11.5
85
339
N05BA01
ATC
diazepam; systemic, rectal
1.5
11.4
423
2946
WX882
NOMESCO Finland
High dependency care
2.3
11.4
108
487
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
6.7
11.4
28
42
TQB05
NOMESCO Finland
Puncture of skin of trunk
3.8
11.4
47
125
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.8
11.4
189
1065
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
3.0
11.3
63
211
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
11.8
11.3
20
17
120
Kela drug reimbursment
Hypogammaglobulinaemia
15.1
11.3
18
12
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.0
11.3
63
212
C83.71
ICD-10 Finland
Burkitt's tumour
35.1
11.3
14
*
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.1
11.3
43
107
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
8.9
11.2
23
26
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
17.1
11.2
17
10
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
11.2
152
798
B37.08
ICD-10 Finland
Other candidal stomatitis
4.3
11.1
40
94
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.1
1221
10187
A04AA03
ATC
tropisetron; systemic
7.6
11.1
25
33
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
20.1
11.1
16
8
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
11.1
201
1164
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.6
11.1
37
81
N63
ICD-10 Finland
Unspecified lump in breast
1.8
11.0
197
1138
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
8.6
11.0
23
27
ZX114
NOMESCO Finland
Intramuscular
2.8
11.0
69
249
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
11.0
38
86
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
9.2
11.0
22
24
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
13.9
11.0
18
13
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.2
10.9
105
478
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
43.4
10.9
13
*
JAH21
NOMESCO Finland
Staging laparoscopy
43.4
10.9
13
*
A07EA06
ATC
budesonide; oral, local oral
2.2
10.9
114
536
L28
ICPC
Limited function/disability (L)
1.4
10.9
473
3406
C56
ICD-10 Finland
Malignant neoplasm of ovary
6.0
10.9
29
49
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
5.3
10.9
32
61
A07EC01
ATC
sulfasalazine; oral, rectal
1.6
10.9
267
1687
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
5.5
10.8
31
57
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
5.7
10.8
30
53
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.9
10.8
26
38
HA1BA
NOMESCO Finland
Extensive X-ray mammography
4.8
10.8
35
74
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.4
10.8
90
382
ZX050
NOMESCO Finland
Stereotactic radiotherapy
4.5
10.8
37
83
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
8.3
10.8
23
28
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
10.8
73
277
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
6.5
10.8
27
42
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
3.3
10.8
52
158
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.7
10.7
71
264
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
5.4
10.7
31
58
J02AC04
ATC
posaconazole; systemic
21.5
10.7
15
7
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
60.2
10.6
12
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
60.2
10.6
12
*
-50
ICPC
Medication/prescr/renewal
1.9
10.6
141
736
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.8
10.5
66
238
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
11.2
10.5
19
17
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.8
10.5
34
72
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
10.5
1293
10933
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
10.4
125
625
D708
ICD-10 Finland
NA
+∞
10.4
10
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
4.1
10.4
39
96
WX002
NOMESCO Finland
Sedation and analgesia
1.4
10.3
645
4948
B74
ICPC
Malignant neoplasm blood other
12.0
10.3
18
15
L01XX52
ATC
venetoclax; oral
32.6
10.3
13
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
10.3
213
1285
B03XA01
ATC
erythropoietin; parenteral
4.2
10.3
38
92
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
4.6
10.3
34
74
K92.1
ICD-10 Finland
Melaena
1.9
10.3
155
847
R04.2
ICD-10 Finland
Haemoptysis
2.2
10.3
103
479
1CD01
NOMESCO Finland
NA
8.8
10.3
21
24
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
7.1
10.2
24
34
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
7.1
10.2
24
34
C20
ICD-10 Finland
Malignant neoplasm of rectum
5.3
10.2
30
57
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
18.8
10.2
15
8
B59
ICD-10 Finland
Pneumocystosis
23.4
10.2
14
6
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.1
10.2
38
93
WX704
NOMESCO Finland
Intubation
1.7
10.2
228
1407
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.6
10.2
112
1989
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.0
10.1
31
62
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
3.3
10.1
50
155
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.3
10.0
36
85
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.5
10.0
44
125
L01EL01
ATC
ibrutinib; oral
40.2
10.0
12
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
5.5
9.9
28
51
B29
ICPC
Lymph/immune mech sympt/complt other
5.5
9.9
28
51
N05AF03
ATC
chlorprothixene; systemic
2.2
9.9
95
432
E83.50
ICD-10 Finland
Hypercalcemia
3.1
9.9
53
174
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
4.9
9.9
31
64
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.9
9.8
147
798
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
12.2
9.8
17
14
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
5.0
9.8
30
60
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
8.1
9.8
21
26
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.1
9.8
52
170
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
3.6
9.8
43
122
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.6
9.8
224
1390
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.0
9.7
53
177
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
9.6
236
1494
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
5.5
9.6
27
49
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
9.6
237
1499
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.9
9.6
143
778
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.2
9.5
92
419
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.9
9.5
55
189
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
9.5
228
1433
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.4
9.5
78
329
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
9.1
9.5
19
21
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
9.1
9.5
19
21
JN5AN
NOMESCO Finland
Total body isotope imaging
15.0
9.5
15
10
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
9.5
154
863
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
4.7
9.5
31
67
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.2
9.5
48
152
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
5.4
9.5
27
50
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
9.5
87
389
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
3.8
9.5
38
100
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
3.0
9.4
52
175
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
100.3
9.4
10
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
100.3
9.4
10
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
30.1
9.4
12
*
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
30.1
9.4
12
*
GD6AD
NOMESCO Finland
CT of chest and neck
7.5
9.4
21
28
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
17.6
9.4
14
8
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
3.1
9.4
49
159
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
5.1
9.4
28
55
N03AX14
ATC
levetiracetam; systemic
2.2
9.3
88
396
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
9.3
78
334
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
4.7
9.3
30
64
Z31.6
ICD-10 Finland
General counselling and advice on procreation
4.0
9.3
35
87
K12.10
ICD-10 Finland
Stomatitis NOS
4.9
9.3
29
60
M05BA04
ATC
alendronic acid; oral
1.6
9.2
247
1600
N05CD07
ATC
temazepam; oral
1.5
9.2
373
2649
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
6.0
9.2
24
40
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
5.4
9.2
26
48
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
9.2
688
5423
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
13.7
9.2
15
11
A08
ICPC
Swelling
1.9
9.2
130
696
D64.8
ICD-10 Finland
Other specified anaemias
2.8
9.2
58
212
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.1
9.1
47
151
QBJ00
NOMESCO Finland
Liposuction in trunk
4.8
9.1
29
61
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
9.1
188
1135
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
3.9
9.1
36
94
HAD40
NOMESCO Finland
Mastopexy
4.6
9.1
30
66
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
11.5
9.1
16
14
GDG10
NOMESCO Finland
Bilateral transplantation of lung
11.5
9.1
16
14
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
9.0
91
423
2AX04
NOMESCO Finland
NA
15.6
9.0
14
9
AAA10
NOMESCO Finland
Biopsy through craniotomy
15.6
9.0
14
9
2AX05
NOMESCO Finland
NA
36.8
9.0
11
*
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
36.8
9.0
11
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
9.0
9.0
18
20
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
9.0
9.0
18
20
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.9
9.0
52
179
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
4.4
9.0
31
71
R60.0
ICD-10 Finland
Localized oedema
1.5
9.0
334
2332
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
4.2
9.0
32
76
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.8
9.0
54
193
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
6.5
8.9
22
34
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
6.5
8.9
22
34
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
18.6
8.9
13
7
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
7.4
8.9
20
27
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
24.1
8.9
12
5
D61.1
ICD-10 Finland
Drug-induced aplastic anaemia
24.1
8.9
12
5
156
Kela drug reimbursment
Lapatinib
24.1
8.9
12
5
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
3.9
8.9
35
91
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.7
8.8
180
1081
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
4.8
8.8
28
59
SPAT1301
SPAT
No procedures
1.3
8.8
1039
8699
K12.18
ICD-10 Finland
Other forms of stomatitis
4.0
8.8
33
82
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
3.9
8.8
34
87
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
8.8
259
1716
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
10.7
8.8
16
15
352
Kela drug reimbursment
Abiraterone and enzalutamide
4.3
8.8
31
73
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
5.1
8.8
26
51
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
8.7
346
2444
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.3
8.7
41
124
E87.6
ICD-10 Finland
Hypokalaemia
2.1
8.7
99
489
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
14.0
8.7
14
10
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
8.7
138
771
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
50.1
8.7
10
*
B00.19
ICD-10 Finland
Other vesicular dermatitis caused by the herper simplex virus
4.2
8.7
31
74
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.5
8.6
29
65
ZY000
NOMESCO Finland
Hospital inpatient
3.1
8.6
44
141
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
8.6
166
984
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.8
8.6
34
89
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
3.7
8.6
36
99
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
6.1
8.6
22
36
SPAT1269
SPAT
Other puncture and/or drainage
4.3
8.6
30
70
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
4.6
8.6
28
61
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
8.6
181
1101
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
5.8
8.6
23
40
N06AX11
ATC
mirtazapine; oral
1.3
8.6
1003
8387
399
Kela drug reimbursment
Venetoclax
16.3
8.5
13
8
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
16.3
8.5
13
8
R33
ICD-10 Finland
Retention of urine
1.6
8.5
199
1245
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.2
8.5
80
361
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
4.8
8.5
27
57
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
9.0
8.5
17
19
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
8.5
121
651
N05AC02
ATC
thioridazine; oral
2.4
8.5
69
292
L01XE07
ATC
[U] lapatinib; oral
27.6
8.5
11
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.5
8.5
28
62
TGA30
NOMESCO Finland
Thoracocentesis
4.1
8.4
31
76
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
6.0
8.4
22
37
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.3
8.4
72
313
9831/3-C42.1
ICD-O-3
T-cell large granular lymphocytic leukemia of bone marrow
90.2
8.4
9
*
1BC01
NOMESCO Finland
NA
90.2
8.4
9
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
8.4
290
1992
153
Kela drug reimbursment
Lenalidomid
4.4
8.4
29
67
GDC00
NOMESCO Finland
Lobectomy of lung
4.7
8.4
27
58
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
4.2
8.4
30
72
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
8.3
8
*
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
8.3
203
1285
WF099
NOMESCO Finland
Other radiotherapy
3.9
8.3
32
82
A07EC02
ATC
mesalazine; oral, rectal
1.7
8.3
165
987
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
3.3
8.3
39
118
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
5.2
8.3
24
46
M05.0
ICD-10 Finland
Felty syndrome
10.7
8.3
15
14
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
5.8
8.3
22
38
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
5.8
8.3
22
38
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
9.4
8.3
16
17
N17.8
ICD-10 Finland
Other acute renal failure
3.1
8.2
42
135
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.7
8.2
164
980
F20
ICD-10 Finland
Schizophrenia
4.8
8.2
26
55
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.8
8.2
132
740
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.3
8.2
72
316
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
5.1
8.1
24
47
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
5.1
8.1
24
47
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
6.0
8.1
21
35
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
8.1
75
338
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.3
8.1
69
298
X77
ICPC
Malignant neopl genital female other
5.7
8.1
22
39
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.3
8.1
28
65
SPAT1234
SPAT
Support of social functional capacity
1.8
8.1
140
803
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
3.2
8.1
40
126
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.3
8.1
74
330
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
33.4
8.1
10
*
B84
ICPC
Unexplained abnormal white cells
33.4
8.1
10
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
33.4
8.1
10
*
369
Kela drug reimbursment
Regorafenib
8.1
8.1
17
21
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
17.2
8.1
12
7
V03AG01
ATC
sodium cellulose phosphate; systemic
11.7
8.1
14
12
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.2
8.0
39
121
F20.5
ICD-10 Finland
Residual schizophrenia
4.4
8.0
27
61
UDC00
NOMESCO Finland
Ear microscopy
1.6
8.0
220
1432
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.4
8.0
68
292
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.8
8.0
32
85
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
8.0
253
1703
L01XX17
ATC
[U] topotecan; systemic
22.1
8.0
11
5
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.3
8.0
68
293
Z2221
NOMESCO Finland
Medical doctor
1.3
8.0
886
7351
WX872
NOMESCO Finland
Intensive care
1.7
8.0
146
852
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
8.0
343
2463
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
5.5
8.0
22
40
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
7.2
7.9
18
25
ZXC40
NOMESCO Finland
Use of ultrasound
3.5
7.9
35
101
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
7.9
770
6279
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
7.9
116
630
RS221
NOMESCO Finland
NA
2.6
7.9
56
221
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
3.6
7.9
33
91
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.4
7.9
27
62
N05AE04
ATC
ziprasidone; systemic
4.4
7.9
27
62
L02BB03
ATC
bicalutamide; oral
2.2
7.9
73
328
QBA00
NOMESCO Finland
Puncture of skin of trunk
4.9
7.9
24
49
A48.8
ICD-10 Finland
Other specified bacterial diseases
13.0
7.9
13
10
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
13.0
7.9
13
10
1XX32
NOMESCO Finland
NA
13.0
7.9
13
10
JJB10
NOMESCO Finland
Atypcal resection of liver
7.8
7.9
17
22
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.5
7.8
26
58
KA1FN
NOMESCO Finland
Isotope renography
3.8
7.8
31
82
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
3.8
7.8
31
82
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
7.8
207
1338
WW400
NOMESCO Finland
Plasmaferesis
10.8
7.8
14
13
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
10.8
7.8
14
13
Z43.3
ICD-10 Finland
Attention to colostomy
9.4
7.8
15
16
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
3.5
7.7
34
98
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.0
7.7
41
136
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.2
7.7
77
358
PJD63
NOMESCO Finland
Laparoscopic dissection of aortic lymph nodes
4.4
7.7
26
59
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
3.7
7.7
32
88
J20.6
ICD-10 Finland
Acute bronchitis due to rhinovirus
15.0
7.7
12
8
D69.4
ICD-10 Finland
Other primary thrombocytopenia
15.0
7.7
12
8
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
7.7
215
1407
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
7.7
100
522
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.8
7.7
133
766
K83.1
ICD-10 Finland
Obstruction of bile duct
2.9
7.6
44
152
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
7.6
60
251
WE100
NOMESCO Finland
Profylactic cytostatic therapy
18.4
7.6
11
6
372
Kela drug reimbursment
Idelalisib
18.4
7.6
11
6
SPAT1290
SPAT
Preparation of deceased person
8.0
7.6
16
20
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
11.9
7.6
13
11
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
11.9
7.6
13
11
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
25.0
7.6
10
*
M05BA06
ATC
ibandronic acid; systemic
2.3
7.6
66
291
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.6
7.5
50
191
-44
ICPC
Preventive immunization/medic
1.5
7.5
255
1747
ECB20
NOMESCO Finland
Oral alveoplasty
3.1
7.5
39
128
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
4.3
7.5
26
61
RF210
NOMESCO Finland
NA
2.0
7.5
94
484
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
4.1
7.5
27
66
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.1
7.5
27
66
E66
ICD-10 Finland
Obesity
0.4
7.4
32
767
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
7.4
285
2004
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
80.2
7.4
8
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
80.2
7.4
8
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
80.2
7.4
8
*
WX720
NOMESCO Finland
Own respiration
1.8
7.4
117
653
L04AX04
ATC
lenalidomide; oral
4.2
7.4
26
62
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
13.4
7.4
12
9
V03AF03
ATC
calcium folinate; systemic
7.6
7.4
16
21
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.6
7.3
51
198
WX610
NOMESCO Finland
Patient controlled analgesia
3.9
7.3
28
72
SPAT1104
SPAT
Monitoring of emergency patient
1.6
7.3
191
1230
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.1
7.3
75
356
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.3
7.3
61
262
D73.5
ICD-10 Finland
Infarction of spleen
+∞
7.3
7
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
7.3
7
*
2888B
ICD-9 Finland
Diseases of white blood cells, Other specified disease of white blood cells[LEUCOPENIA]
+∞
7.3
7
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
2.6
7.3
51
200
XX4BW
NOMESCO Finland
NA
6.8
7.3
17
25
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
9.4
7.3
14
15
B99
ICPC
Blood/lymph/spleen disease other
4.9
7.3
22
45
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.3
7.2
34
104
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
5.1
7.2
21
41
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
6.2
7.2
18
29
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
6.2
7.2
18
29
WE198
NOMESCO Finland
Palliative cystotatic therapy
15.8
7.2
11
7
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
5.4
7.2
20
37
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
4.3
7.2
25
59
UKC02
NOMESCO Finland
Cystoscopy
1.3
7.2
452
3465
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
7.2
149
906
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
30.1
7.1
9
*
N99.0
ICD-10 Finland
Postprocedural renal failure
20.0
7.1
10
5
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
4.4
7.1
24
55
N05AB03
ATC
perphenazine; systemic, rectal
1.8
7.1
111
618
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
7.1
805
6684
A04
ICPC
Weakness/tiredness general
1.4
7.1
362
2682
A11CC03
ATC
alfacalcidol; systemic
2.2
7.1
70
325
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
4.2
7.1
25
60
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
7.1
1490
13210
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
5.3
7.1
20
38
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
5.6
7.0
19
34
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
5.6
7.0
19
34
L01BC53
ATC
tegafur, combinations; systemic
8.8
7.0
14
16
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
10.0
7.0
13
13
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.7
7.0
43
158
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
4.1
7.0
25
61
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
3.5
7.0
30
86
SPAT1240
SPAT
Therapeutic discussion
1.4
7.0
301
2167
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
3.1
6.9
35
113
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
6.9
163
1022
116
Kela drug reimbursment
Prostate cancer
1.7
6.9
133
789
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.9
6.9
40
139
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
6.3
6.9
17
27
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
6.3
6.9
17
27
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
6.3
6.9
17
27
E86
ICD-10 Finland
Volume depletion
2.2
6.9
67
311
M35.1
ICD-10 Finland
Other overlap syndromes
4.2
6.9
24
57
JLC30
NOMESCO Finland
Pancreatoduodenectomy
4.2
6.9
24
57
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
3.4
6.9
31
92
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
7.5
6.9
15
20
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
7.5
6.9
15
20
HAD20
NOMESCO Finland
Liposuction of breast
7.5
6.9
15
20
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
4.6
6.9
22
48
R55
ICD-10 Finland
Syncope and collapse
1.4
6.9
290
2078
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.0
6.8
37
126
5AB14
NOMESCO Finland
NA
8.3
6.8
14
17
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
6.8
311
2258
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
6.7
6.8
16
24
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
10.9
6.8
12
11
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
10.9
6.8
12
11
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
10.9
6.8
12
11
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.4
6.8
30
88
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
4.0
6.8
25
63
D76
ICPC
Malignant neoplasm pancreas
6.1
6.8
17
28
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
5.6
6.7
18
32
D75.2
ICD-10 Finland
Essential thrombocytosis
16.7
6.7
10
6
1518
Kela drug reimbursment
NA
16.7
6.7
10
6
P28
ICPC
Limited function/disability (P)
3.3
6.7
31
94
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.7
204
1365
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
4.3
6.7
23
54
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.7
6.7
21
45
191
Kela drug reimbursment
Erlotinib
7.2
6.7
15
21
F20.19
ICD-10 Finland
Hebefren schizophrenia UNS
7.2
6.7
15
21
K83.0
ICD-10 Finland
Cholangitis
2.5
6.7
48
193
1DB03
NOMESCO Finland
NA
22.5
6.7
9
*
3AC01
NOMESCO Finland
NA
2.8
6.7
40
145
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.6
6.7
28
79
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.7
6.7
256
3487
RF120
NOMESCO Finland
NA
2.7
6.7
43
161
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.4
6.6
30
90
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.1
6.6
34
112
N02AA03
ATC
hydromorphone; systemic, rectal
5.9
6.6
17
29
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
4.2
6.6
23
55
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.9
6.6
87
459
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
3.9
6.6
25
65
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
6.5
133
806
HAC25
NOMESCO Finland
Radical mastectomy
4.8
6.5
20
42
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
6.5
374
2827
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.5
727
6020
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
4.1
6.5
23
56
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.5
6.5
46
183
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.2
6.5
59
268
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.2
6.5
63
292
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
5.3
6.4
18
34
1XC07
NOMESCO Finland
NA
5.3
6.4
18
34
E000006
ATC
NA
1.5
6.4
217
1488
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
70.0
6.4
7
*
1XC14
NOMESCO Finland
NA
70.0
6.4
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
70.0
6.4
7
*
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
7.4
6.4
14
19
Z51.88
ICD-10 Finland
Other specified medical care
2.2
6.4
58
262
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.7
6.4
119
700
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
14.3
6.4
10
7
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
14.3
6.4
10
7
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.4
546
4374
RD211
NOMESCO Finland
NA
1.6
6.4
141
872
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.6
6.4
26
72
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
2.2
6.4
60
275
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
8.1
6.3
13
16
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
6.3
192
1287
Z94.4
ICD-10 Finland
Liver transplant status
5.2
6.3
18
35
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.6
6.3
43
169
RS140
NOMESCO Finland
NA
5.9
6.3
16
27
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
5.9
6.3
16
27
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
5.5
6.3
17
31
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
5.5
6.3
17
31
E87.5
ICD-10 Finland
Hyperkalaemia
2.4
6.3
48
198
K56.7
ICD-10 Finland
Ileus, unspecified
2.4
6.3
51
217
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
9.3
6.3
12
13
8441/3-C54.1
ICD-O-3
Serous carcinoma, NOS, of endometrium
9.3
6.3
12
13
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
3.6
6.3
26
73
RS121
NOMESCO Finland
NA
3.7
6.3
25
68
X19
ICPC
Breast lump/mass female
2.3
6.3
54
238
J05AX18
ATC
letermovir; oral
+∞
6.2
6
*
1DB06
NOMESCO Finland
NA
+∞
6.2
6
*
2880X
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, NUD]
+∞
6.2
6
*
2880A
ICD-9 Finland
Diseases of white blood cells, Agranulocytosis[AGRANULOCYTOSIS, IDIOPATHICA]
+∞
6.2
6
*
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
3.3
6.2
29
89
TJF80
NOMESCO Finland
Ostomy education
2.9
6.2
36
126
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
6.2
162
1046
WPB10
NOMESCO Finland
Making a convalescent care decision
26.7
6.2
8
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
26.7
6.2
8
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
26.7
6.2
8
*
Z72.8
ICD-10 Finland
Other problems related to lifestyle
4.3
6.2
21
49
KA3EB
NOMESCO Finland
Antegrade pyelography
4.3
6.2
21
49
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
4.8
6.2
19
40
176
Kela drug reimbursment
Regorafenib
7.0
6.2
14
20
N03AX09
ATC
lamotrigine; oral
1.7
6.2
131
803
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.1
6.2
22
54
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
6.2
478
3778
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
5.0
6.2
18
36
RD210
NOMESCO Finland
NA
2.2
6.2
59
274
Y77
ICPC
Malignant neoplasm prostate
2.0
6.1
71
357
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
5.3
6.1
17
32
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
5.3
6.1
17
32
B81
ICPC
Anaemia vit B12/folate deficiency
1.7
6.1
108
627
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
3.3
6.1
28
85
F25
ICD-10 Finland
Schizoaffective disorders
5.7
6.1
16
28
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.0
6.1
68
335
29599
ICD-8 Finland
Schizophrenia, Unspecified type
4.2
6.1
21
50
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.4
6.1
48
204
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
4.7
6.1
19
41
B04
ICPC
Blood symptom/complaint
4.7
6.1
19
41
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
12.5
6.1
10
8
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
12.5
6.1
10
8
E000003
ATC
NA
1.7
6.1
128
783
GX1K5
NOMESCO Finland
Diffusion capacity
8.6
6.0
12
14
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
6.0
202
1383
C10AA07
ATC
rosuvastatin; oral
0.8
6.0
502
6166
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
4.4
6.0
20
46
D75.1
ICD-10 Finland
Secondary polycythaemia
10.0
6.0
11
11
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
10.0
6.0
11
11
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
10.0
6.0
11
11
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
10.0
6.0
11
11
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
6.7
6.0
14
21
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
3.3
6.0
27
81
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
6.0
398
3076
137
Kela drug reimbursment
Uraemia requiring dialysis
3.0
6.0
31
103
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.5
6.0
43
172
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023520) Reticulocytes [#/volume] in Blood
1011
2867
4.29
320.70
4.8
2.5
e9/l
66.2
69.8
2.21
827
2137
(3022096) Basophils/100 leukocytes in Blood
3012
16656
3.61
307.65
13.2
6.0
%
0.7
0.7
1.25
2917
15504
(3006504) Eosinophils/100 leukocytes in Blood
3070
17155
3.66
307.65
13.3
5.9
%
2.4
2.9
24.15
2967
15960
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
510
530
10.76
307.65
4.4
2.9
u/ml
13108.2
1580.5
0.56
51
32
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
340
259
14.15
307.65
2.8
2.2
%
10.7
13.4
1.98
112
121
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1600
5891
3.71
307.65
9.0
3.3
mmol/l
0.8
0.8
19.37
1553
5490
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1462
3886
5.15
307.65
9.1
3.8
u/l
250.3
244.1
0.66
1419
3667
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
648
689
10.87
307.65
8.6
5.0
iu/ml
2650.8
567.3
0.44
96
90
(3004809) Band form neutrophils/100 leukocytes in Blood
495
538
10.25
307.65
5.1
3.0
%
1.9
1.3
2.24
427
415
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
344
247
15.03
307.65
2.7
2.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2564
9480
5.13
307.65
8.5
4.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
343
265
13.96
307.65
2.8
2.2
%
74.8
72.4
1.22
333
252
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
619
828
8.54
307.65
2.7
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
493
307
17.97
307.65
1.7
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
3583
21289
4.81
307.65
32.6
8.7
e9/l
3.0
4.1
195.92
3418
18489
(3019069) Monocytes/100 leukocytes in Blood
3102
17257
3.75
307.65
13.9
6.2
%
9.9
8.6
41.75
3005
16141
(3005719) IgG [Mass/volume] in Serum or Plasma
986
2710
4.41
307.65
4.8
2.7
g/l
9.6
10.5
4.96
937
2477
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
968
2597
4.50
307.65
2.4
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
635
850
8.57
307.65
2.5
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
407
328
13.58
307.65
3.2
2.2
e9/l
1.0
1.1
0.87
297
199
(3027945) Reticulocytes/100 erythrocytes in Blood
1250
3851
4.15
307.65
5.1
2.5
%
1.7
1.8
1.59
1173
3427
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
539
604
10.04
307.65
2.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
453
477
10.48
307.65
2.0
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
375
391
10.40
307.65
2.1
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1073
2870
4.63
307.65
7.1
3.9
%
0.2
0.1
5.81
719
735
(3042111) Morphology [Interpretation] in Bone marrow Narrative
616
509
13.92
307.65
2.4
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
3123
17721
3.68
307.65
13.5
6.0
%
30.2
28.2
10.88
3021
16474
(4035726)
1152
3299
4.38
307.65
1.7
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1188
2999
5.07
307.65
6.9
3.9
%
1.4
0.8
7.75
786
790
(3002179) Metamyelocytes/100 leukocytes in Blood
1006
2760
4.44
307.65
6.7
3.7
%
0.9
0.6
4.29
551
575
(21494815) CD4 cells/100 lymphocytes in Specimen
355
275
13.96
307.65
2.8
2.2
%
34.4
47.4
2.88
29
31
(42870588) Differential panel, method unspecified - Blood
2559
12522
3.52
307.65
12.8
5.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1585
5774
3.74
307.65
3.0
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3298
18971
4.02
307.65
18.1
6.1
umol/l
10.6
11.4
2.12
3222
17964
(3010503) CD19 cells [#/volume] in Blood
293
202
15.48
307.65
3.2
2.1
e9/l
0.1
0.2
0.94
287
193
(3018010) Neutrophils/100 leukocytes in Blood
3023
17481
3.37
301.70
12.5
5.9
%
52.3
57.0
43.92
2919
16317
(21494434) Karyotype in Bone marrow
300
260
12.31
295.00
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
938
2708
4.14
288.05
7.4
4.0
%
0.1
0.3
0.64
604
624
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1174
3973
3.67
286.27
2.5
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
3087
18398
3.31
285.80
12.5
5.8
e9/l
0.0
0.0
69.78
2836
15793
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1174
3982
3.66
285.17
2.6
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
3075
18322
3.29
284.02
12.5
5.8
e9/l
0.5
0.6
3.48
2828
15733
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
628
1337
5.32
282.51
2.6
1.9
ug/l
1.6
2.3
0.78
595
1189
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
213
106
21.07
280.82
2.4
2.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
3136
19014
3.30
278.66
13.9
6.0
e9/l
0.1
0.2
110.82
2897
16599
(21494814) CD8 cells/100 lymphocytes in Specimen
227
133
17.95
277.74
2.6
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
3114
18846
3.27
276.69
12.7
5.8
e9/l
1.6
1.9
5.56
2892
16505
(3028026) IgM [Mass/volume] in Serum or Plasma
800
2119
4.40
275.03
2.7
1.9
g/l
1.1
1.4
2.08
750
1938
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
273
231
12.54
272.34
1.5
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
225
146
16.19
261.37
4.9
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3027
18377
3.11
260.19
14.7
6.6
mmol/l
1.2
1.2
0.70
2426
15547
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
359
478
8.09
256.41
1.9
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
2130
10807
2.90
254.25
9.5
3.9
ph
7.4
7.4
0.23
672
2026
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
402
620
7.04
251.75
1.9
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2804
16703
2.90
242.25
12.5
6.0
mmol/l
1.2
1.2
0.86
2682
15108
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
259
253
10.82
234.62
1.8
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
823
2516
3.80
229.33
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
403
687
6.36
228.64
1.6
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
421
792
5.78
215.44
1.9
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
297
392
8.06
213.17
2.7
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
368
618
6.41
211.62
1.6
1.4
u/ml
102.6
116.1
0.90
86
116
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
342
539
6.80
209.17
1.9
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
284
366
8.23
207.92
6.7
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
318
467
7.27
207.71
1.9
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
233
233
10.51
207.40
3.8
2.2
e6/l
473.6
708.2
3.84
85
94
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
272
338
8.51
205.20
1.4
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
244
264
9.73
205.09
2.0
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1038
3946
3.14
202.44
1.7
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
276
359
8.14
200.42
2.8
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2594
15754
2.59
200.01
9.7
4.8
g/l
33.3
35.6
62.01
2482
14623
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
117
26
46.21
198.97
2.3
2.2
mg/l
1.4
2.2
0.39
77
20
(40760892) CBC W Ordered Manual Differential panel - Blood
1625
7929
2.67
197.72
9.9
4.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
268
355
7.98
191.53
1.4
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3793
28339
3.58
189.10
21.9
7.4
u/l
85.9
78.8
11.40
3717
26639
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
220
232
9.93
188.33
3.6
2.3
e6/l
565.0
526.8
0.29
178
193
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
978
3810
3.02
180.73
5.8
4.0
ug/l
27.2
23.1
0.24
812
3044
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
361
693
5.59
180.09
1.4
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1129
4819
2.81
175.70
10.4
5.8
mmol/l
1.0
1.1
0.36
1090
4466
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
202
214
9.85
172.22
2.0
1.4
—
—
—
0
0
(44806118)
277
428
6.84
172.18
2.1
1.5
—
—
—
0
0
(44790049)
277
428
6.84
172.18
2.1
1.5
—
—
—
0
0
(44790048)
277
428
6.84
172.18
2.1
1.5
—
—
—
0
0
(44790047)
277
428
6.84
172.18
2.1
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
205
223
9.60
171.37
3.9
2.3
e9/l
0.2
0.2
1.28
175
193
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
336
655
5.47
164.56
1.4
1.2
u/ml
256.3
266.9
0.25
223
384
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
185
187
10.29
163.14
2.1
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1122
4937
2.71
163.12
1.7
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
432
1052
4.45
162.22
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
184
188
10.17
161.00
2.1
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1142
5115
2.67
159.85
2.2
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1496
7634
2.46
158.86
3.5
2.6
e6/l
6.4
5.7
1.18
1375
6679
(3026782) Osmolality of Urine
1416
7049
2.49
158.71
3.6
2.7
mosm/kgh2o
511.6
542.5
6.54
1288
5982
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
802
2992
3.06
158.26
9.5
3.6
mmol/l
1.2
1.2
1.02
767
2597
(3002582) Erythrocytes [#/volume] in Urine
1916
10926
2.34
157.76
4.5
3.2
e6/l
106.0
67.9
0.47
1641
8330
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
422
1039
4.39
156.08
1.9
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
1724
9450
2.36
154.95
23.9
6.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
773
2914
3.01
149.11
3.9
2.6
g/l
65.2
66.4
3.42
740
2672
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
215
301
7.46
146.06
3.1
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
215
301
7.46
146.06
3.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
215
301
7.46
146.06
3.1
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2075
12547
2.25
144.94
8.2
3.3
mmol/l
2.3
2.4
6.44
1939
10922
(46235355) HIV 1 and 2 tests - Meaningful Use set
1211
5834
2.49
143.50
1.9
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2499
16341
2.24
143.15
23.8
9.2
e9/l
0.0
0.0
2.55
2166
13267
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
333
733
4.84
141.39
1.7
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2285
14484
2.21
140.52
10.1
8.9
inr
1.2
1.2
8.05
886
4160
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
419
1144
3.94
134.23
2.8
2.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1932
11667
2.18
131.72
5.3
2.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
392
1036
4.06
131.32
4.2
2.9
g/l
3.4
3.6
0.85
377
983
(3004588) Protein electrophoresis panel - Serum or Plasma
651
2393
3.02
130.21
3.1
2.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1129
5523
2.41
127.23
3.6
2.2
s
29.6
29.8
0.53
1111
5364
(3030467) Casts [#/volume] in Urine by Automated count
1724
10081
2.17
126.25
4.3
3.1
e6/l
0.4
0.4
0.05
1452
7565
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
576
2019
3.13
124.89
1.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2536
17229
2.13
124.69
7.8
4.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
208
333
6.51
124.58
1.3
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
485
1538
3.42
123.97
1.9
1.7
g/l
1.5
1.6
0.41
417
1324
(3018095) Leukocytes [#/volume] in Urine
2049
12869
2.12
123.89
5.3
3.7
e6/l
111.6
104.6
0.09
1683
9036
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
212
349
6.33
123.53
2.7
2.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
159
191
8.60
122.82
4.3
2.6
%
37.7
41.6
0.91
47
66
(3031040) Bacteria [#/volume] in Urine by Automated count
3218
24129
2.27
120.78
6.0
4.5
e6/l
1028.8
1687.8
0.48
99
312
(36304419) Bacteria [Presence] in Urine
1670
9837
2.13
118.13
4.1
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2943
21409
2.15
117.63
9.1
4.7
mmol/l
6.6
6.7
0.65
2837
20025
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
178
261
7.07
115.80
2.0
1.9
mg/l
4.0
4.4
0.40
169
254
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
118
102
11.86
115.50
1.3
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1043
5143
2.35
113.82
2.8
2.5
g/l
2.2
2.3
13.56
992
4762
(3037692) Legionella sp identified in Specimen by Organism specific culture
125
121
10.60
113.44
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
988
4771
2.38
113.01
2.9
2.6
%
25.0
22.8
3.67
888
4076
(3000093) Morphology [Interpretation] in Blood Narrative
189
311
6.31
110.09
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
832
3759
2.50
109.95
5.9
3.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
362
1027
3.75
109.21
1.8
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1090
5572
2.27
108.63
2.9
2.5
umol/l
13.1
13.1
0.04
1040
5169
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1827
11437
2.03
106.84
3.6
2.6
u/l
52.9
57.9
5.26
1737
10530
(3008536) Aspergillus sp Ab [Presence] in Serum
91
59
15.73
105.24
3.5
1.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
122
129
9.70
103.90
3.0
2.5
%
34.5
28.4
2.59
115
122
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
122
132
9.48
102.13
4.1
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
122
132
9.48
102.13
4.1
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
137
172
8.19
102.00
3.8
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
137
172
8.19
102.00
3.8
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
137
172
8.19
102.00
3.8
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
137
172
8.19
102.00
3.8
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
122
134
9.34
100.98
4.1
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
768
3488
2.46
99.52
2.8
2.3
g/l
0.2
0.2
5.75
715
3273
(3006245) CD3-CD19+ cells/100 cells in Blood
121
136
9.12
98.40
3.2
2.7
%
11.0
10.7
0.08
108
127
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
112
115
9.97
97.43
1.9
2.4
u/ml
515.5
25464.6
0.57
12
20
(3026008) Bacteria identified in Urine by Culture
1753
11096
1.97
96.73
3.6
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
856
4145
2.32
95.63
5.8
2.7
umol/l
11.5
7.9
2.65
770
3599
(3017354) Segmented neutrophils/100 leukocytes in Blood
185
349
5.49
93.37
5.8
2.8
%
50.1
57.7
3.12
117
227
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1834
11898
1.93
93.12
6.8
3.2
u/l
36.0
34.5
0.44
1754
11286
(3000060) B lymphocytes [#/volume] in Blood
101
96
10.75
92.75
3.1
2.7
e6/l
204.0
235.0
0.22
55
54
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
121
149
8.32
91.50
1.3
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
215
477
4.69
89.92
6.9
6.6
mg/l
11.5
11.7
0.22
200
448
(3036481) Cortisol [Moles/volume] in Serum or Plasma
735
3415
2.39
89.82
2.6
2.2
nmol/l
375.1
371.4
0.15
696
3127
(40761536) Microorganisms panel - Urine sediment
676
3051
2.44
88.02
5.1
3.9
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
100
102
10.01
87.38
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
210
472
4.62
86.41
2.3
2.9
—
—
—
0
0
(3024471) HLA-A [Type]
100
111
9.20
82.06
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
306
941
3.42
81.23
1.3
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
684
3225
2.33
80.15
13.0
7.4
mmol/l
9.1
9.6
1.02
660
3076
(40758292) HTLV I+II Ab panel - Serum
69
45
15.56
79.45
1.5
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1481
9322
1.89
79.30
7.7
3.9
%
89.2
91.2
2.52
1450
9082
(3007164) IgA [Mass/volume] in Serum or Plasma
1222
7232
1.96
78.74
2.3
1.5
g/l
2.2
2.4
3.23
924
4289
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
261
742
3.68
78.06
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
261
742
3.68
78.06
1.6
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
493
2033
2.61
77.22
1.5
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
337
1140
3.12
76.41
4.2
2.6
%
88.1
91.3
1.47
317
1075
(3024932) HLA-DR beta [Type]
95
109
8.89
75.98
1.4
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
91
99
9.37
75.81
4.7
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3144
25138
1.90
75.36
6.2
4.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
113
163
7.09
74.51
2.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
113
163
7.09
74.51
2.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1435
9085
1.86
74.45
2.5
2.3
mg/l
3.2
2.9
2.16
1274
7748
(3012501) Base excess in Blood by calculation
264
795
3.47
72.29
4.3
4.1
mmol/l
2.3
2.6
1.02
196
540
(3013290) Carbon dioxide [Partial pressure] in Blood
264
796
3.47
72.15
4.3
4.1
kpa
4.9
5.0
3.40
259
782
(3027315) Oxygen [Partial pressure] in Blood
264
802
3.44
71.30
4.3
4.2
kpa
8.6
8.6
0.05
259
787
(3007853) Bacteria identified in Skin by Aerobe culture
808
4255
2.10
71.28
1.9
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1399
8938
1.83
69.49
4.8
2.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
54
28
19.51
69.39
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
181
440
4.25
67.29
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
237
699
3.53
66.96
1.8
1.6
—
—
—
0
0
(3010421) pH of Blood
283
939
3.15
66.15
4.4
3.9
ph
7.4
7.4
4.93
259
781
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
46
18
25.81
66.06
3.5
3.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1437
9381
1.79
65.65
6.0
2.6
umol/l
1702.1
4833.9
4.66
1332
8124
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
322
1171
2.89
64.00
3.9
3.5
u/ml
0.3
0.4
0.96
203
679
(3021447) Carbon dioxide [Partial pressure] in Venous blood
663
3369
2.14
63.62
7.6
3.9
kpa
5.7
5.9
4.75
643
3276
(3048879) Bone marrow aspiration report
76
83
9.30
63.11
3.3
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
506
2311
2.35
62.95
10.7
7.9
mmol/l
24.9
24.9
0.05
500
2296
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
297
1047
2.97
62.43
4.1
3.4
ratio
3.4
2.2
0.41
17
87
(3026250) Tacrolimus [Mass/volume] in Blood
99
150
6.73
62.36
39.3
33.6
ug/l
7.4
7.3
0.09
90
134
(3002032) Base excess in Venous blood by calculation
658
3362
2.13
62.15
7.7
3.9
mmol/l
2.1
1.9
0.48
539
2740
(3012544) pH of Venous blood
674
3478
2.11
62.02
7.5
3.9
ph
7.4
7.4
—
5
16
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
302
1081
2.93
61.75
4.1
3.5
mg/l
31.7
62.6
1.57
221
881
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
467
2078
2.40
61.58
7.9
3.5
u/ml
61.9
54.6
0.34
450
2003
(3032352) Blasts [#/volume] in Cerebral spinal fluid
56
40
14.17
61.31
4.5
2.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
301
1082
2.91
61.06
4.1
3.5
mg/l
71.5
109.7
0.30
222
881
(40767503) Oxygen content in Capillary blood by calculation
235
733
3.33
60.76
2.9
2.4
%
15.0
16.1
3.40
116
376
(3029937) Albumin [Presence] in Urine by Test strip
1437
9549
1.75
60.72
5.3
4.1
estimate
0.0
0.0
1.49
697
3210
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
120
226
5.43
60.60
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
247
801
3.21
59.92
3.9
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
781
4304
1.99
59.82
2.1
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
270
924
3.05
59.77
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
241
780
3.21
58.65
4.2
3.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
59
52
11.49
56.90
1.7
2.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
84
118
7.24
56.72
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1869
13561
1.66
55.70
4.2
3.5
ng/l
56.3
80.5
0.22
1451
9161
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
48
31
15.64
55.45
1.1
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
62
62
10.13
54.88
1.5
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
100
176
5.79
54.30
32.4
25.0
ug/l
135.8
117.9
1.30
80
145
(3016650) Hepatitis A virus Ab [Presence] in Serum
192
576
3.44
52.76
1.2
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
35
12
29.39
52.41
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
472
2276
2.20
51.11
6.9
4.1
mmol/l
2.1
1.8
1.05
355
1701
(3009343) pH of Capillary blood
484
2359
2.18
51.02
6.9
4.2
ph
7.4
7.4
2.52
87
265
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
277
1048
2.75
50.93
4.3
2.8
%
201.7
190.8
1.15
265
1000
(3028271) Lactate [Moles/volume] in Capillary blood
183
546
3.45
50.71
2.2
1.9
mmol/l
1.8
1.7
0.42
178
534
(40760409) HLA-A [Type] by High resolution
34
12
28.55
50.42
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
34
12
28.55
50.42
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
34
12
28.55
50.42
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
34
12
28.55
50.42
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
351
1502
2.45
50.14
3.7
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
261
965
2.81
50.12
8.8
4.3
mg/l
1.5
1.5
0.07
244
890
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1215
8050
1.71
49.94
2.6
1.8
mg/l
1.9
1.2
4.53
962
6121
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
485
2389
2.16
49.72
6.9
4.2
kpa
5.0
5.2
2.90
458
2231
(3014576) Chloride [Moles/volume] in Serum or Plasma
770
4473
1.88
49.51
10.2
7.0
mmol/l
104.2
104.4
0.56
742
4379
(1617658) Protocol used for examination of sentinel lymph nodes
131
315
4.26
49.38
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
94
171
5.60
49.30
1.7
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
446
2134
2.21
49.15
2.4
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
237
846
2.90
48.56
2.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
576
3052
2.02
48.54
10.9
8.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
150
405
3.80
48.25
2.9
1.9
ug/l
22.2
25.0
0.31
150
398
(3001964) Herpes simplex virus Ag [Presence] in Specimen
74
109
6.89
47.86
2.1
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
248
920
2.80
47.30
7.7
4.6
kpa
8.4
8.4
0.26
236
858
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
322
1364
2.47
46.96
3.3
2.3
g/l
3.9
3.8
0.20
242
986
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
322
1364
2.47
46.96
3.3
2.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
291
1175
2.58
46.95
3.6
2.3
g/l
1.7
1.0
1.33
260
1020
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
322
1365
2.47
46.88
3.3
2.3
g/l
7.2
7.4
1.31
248
1037
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
185
584
3.26
46.85
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2266
17729
1.58
46.37
5.1
3.7
estimate
0.0
0.0
0.80
733
3237
(3021601) Nitrite [Presence] in Urine by Test strip
2272
17793
1.58
46.25
6.5
4.9
estimate
0.0
0.0
0.80
743
3296
(3014111) Lactate [Moles/volume] in Serum or Plasma
579
3127
1.98
46.08
8.9
7.3
mmol/l
1.4
1.3
0.34
564
3014
(3009261) Glucose [Presence] in Urine by Test strip
2290
17987
1.57
45.86
5.1
3.7
estimate
0.0
0.0
1.32
738
3222
(3023419) Bacteria identified in Sputum by Culture
160
469
3.50
45.56
2.5
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
71
106
6.79
45.36
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1358
9469
1.63
44.87
4.9
3.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
304
1281
2.48
44.80
3.4
2.3
g/l
3.2
3.1
0.93
243
1012
(40768804) Tissue Pathology biopsy report
1992
15243
1.56
44.11
2.5
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
242
923
2.72
43.73
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
186
614
3.12
43.72
3.0
2.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
236
890
2.75
43.59
3.4
3.1
mmol/l
24.3
25.1
1.72
216
782
(3019309) Folate [Moles/volume] in Red Blood Cells
1011
6577
1.70
43.52
1.9
1.7
nmol/l
1275.3
1167.5
3.16
827
4952
(3037522) Nuclear Ab [Titer] in Serum
811
4976
1.77
42.98
1.5
1.3
titre
743.3
532.1
1.61
177
1054
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2028
15654
1.55
42.71
3.6
2.8
ug/l
328.3
121.9
22.78
1922
14473
(3036489) Thrombin time
313
1368
2.39
42.53
3.9
2.3
s
22.0
21.5
0.92
290
1202
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
258
1033
2.59
42.30
3.4
2.2
g/l
0.0
0.0
1.26
245
953
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
905
5762
1.72
41.97
4.1
2.9
e6/l
2.9
2.7
0.17
555
3090
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
124
325
3.90
41.61
4.0
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1396
9947
1.59
41.47
1.7
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
75
130
5.85
41.40
1.1
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
631
3628
1.86
41.30
9.4
8.0
%
95.5
95.8
0.45
613
3495
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
66
101
6.62
41.20
1.2
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
45
43
10.56
41.08
2.0
2.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
374
1794
2.19
40.72
4.1
2.8
e6/l
0.2
0.3
1.28
368
1746
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
264
1089
2.52
40.67
2.6
1.6
g/l
0.2
0.2
6.49
246
1035
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
299
1316
2.37
39.95
4.5
3.4
u/ml
2622.2
3413.1
0.10
264
1109
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
306
1366
2.33
39.58
2.5
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
291
1271
2.38
39.56
3.4
2.3
g/l
10.8
10.3
0.82
259
1085
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
83
165
5.11
39.50
2.5
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
83
165
5.11
39.50
2.5
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
127
356
3.64
38.70
1.4
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
58
83
7.07
38.53
1.5
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
370
1808
2.14
38.38
9.0
4.5
mmol/l
24.3
24.1
0.74
342
1636
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
232
926
2.59
38.25
1.8
1.9
mg/l
11.0
11.2
0.06
214
851
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1004
6711
1.64
38.24
5.5
3.0
mmol/l
2.5
2.5
2.91
925
5893
(3003396) Base excess in Arterial blood by calculation
676
4061
1.79
38.10
9.1
7.5
mmol/l
1.7
1.1
4.23
543
3162
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
95
218
4.43
38.07
2.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
94
214
4.47
38.05
2.4
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1779
13581
1.52
37.92
5.3
3.9
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
265
1133
2.43
37.76
2.6
1.6
g/l
1.1
1.2
4.35
250
1078
(3021960) Folate [Moles/volume] in Serum or Plasma
1196
8368
1.59
37.66
1.7
1.5
nmol/l
20.0
20.7
0.90
1086
7105
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
65
108
6.09
37.47
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
148
470
3.22
37.12
2.9
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
150
481
3.19
37.02
2.9
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
92
211
4.43
36.90
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
149
477
3.20
36.88
3.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
148
472
3.21
36.86
2.9
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
674
4083
1.77
36.82
9.0
7.5
kpa
12.4
12.6
0.40
652
3894
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
674
4084
1.77
36.78
9.0
7.5
kpa
5.0
5.1
2.47
648
3892
(3024354) Oxygen [Partial pressure] in Venous blood
503
2785
1.91
36.75
7.4
3.3
kpa
4.7
4.6
0.17
489
2702
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
148
473
3.20
36.73
2.9
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
148
474
3.20
36.61
2.9
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
234
962
2.51
36.27
3.4
2.2
g/l
0.0
0.0
0.00
221
887
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
46
54
8.60
36.10
1.6
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1972
15497
1.50
35.93
2.9
2.3
nmol/l
77.7
78.0
0.19
1845
13913
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
168
590
2.92
35.43
1.2
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
200
771
2.67
35.36
4.5
3.4
u/ml
208.9
669.6
0.74
188
706
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
230
952
2.49
35.14
3.5
2.2
g/l
0.0
0.0
0.00
221
886
(3003434) Protein [Mass/volume] in Pleural fluid
142
455
3.19
35.10
1.4
1.5
g/l
36.0
33.1
2.13
130
411
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1379
10100
1.53
34.92
3.6
3.0
ng/l
1536.5
1319.5
0.83
1230
8615
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3977
36671
1.95
34.41
40.4
13.7
mg/l
27.2
23.3
12.53
3629
28874
(3019060) Gas panel - Arterial blood
431
2327
1.95
33.84
6.6
5.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
566
3352
1.79
33.17
9.9
8.3
g/l
112.1
121.5
22.29
546
3230
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
56
92
6.15
32.66
1.4
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
244
1078
2.34
32.25
3.4
2.1
g/l
37.0
37.6
0.76
228
931
(3052851) Hemolysis interference index of Serum or Plasma
244
1078
2.34
32.25
4.1
3.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
408
2209
1.93
31.71
9.4
7.1
mmol/l
24.7
24.6
0.15
390
2050
(3002256) Pathology report gross observation
749
4870
1.65
31.07
1.4
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
89
229
3.95
30.70
1.4
1.4
u/l
12.7
12.8
0.04
89
218
(3013707) Erythrocyte sedimentation rate by Westergren method
3127
27402
1.50
30.26
6.7
4.1
mm/h
17.5
12.1
42.46
2948
25359
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
80
194
4.18
29.90
12.2
17.8
nmol/l
1472.4
1494.6
0.06
73
189
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
119
379
3.20
29.74
1.2
1.2
u/l
90.5
58.6
1.78
92
257
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
233
1046
2.30
29.66
1.4
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
112
345
3.31
29.56
1.4
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
196
817
2.46
29.49
2.7
1.5
e6/l
67.6
31.1
0.28
167
619
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3384
36766
0.65
29.36
4.5
4.9
mmol/l
2.7
2.8
3.28
3064
33834
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
213
929
2.36
28.99
2.3
1.4
mg/l
662.3
521.0
0.56
204
874
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
195
818
2.45
28.94
2.7
1.5
e6/l
204.3
1426.5
2.27
176
655
(3009466) Valproate [Moles/volume] in Serum or Plasma
142
511
2.84
28.67
6.8
5.2
umol/l
395.6
364.3
1.58
128
447
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
897
6232
1.55
27.84
3.8
2.7
e6/l
1.3
1.1
0.30
552
3530
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3287
35852
0.66
27.77
4.2
4.4
mmol/l
1.5
1.5
2.80
2984
33007
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
136
488
2.84
27.61
1.4
1.4
nmol/l
0.3
0.4
1.28
85
374
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
110
352
3.18
27.30
1.6
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
293
1488
2.04
27.26
1.5
1.6
u/ml
15.1
15.8
—
8
41
(3024980) IgG subclass 4 [Mass/volume] in Serum
148
566
2.67
26.61
1.5
1.6
g/l
0.5
0.8
2.60
108
428
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
61
131
4.71
26.59
4.7
2.3
nmol/l
179.4
149.8
1.36
56
113
(3027273) Bicarbonate [Moles/volume] in Venous blood
318
1678
1.97
26.55
5.2
3.2
mmol/l
25.2
25.4
0.46
304
1623
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
170
698
2.49
26.43
1.6
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3324
36106
0.67
26.38
4.3
4.4
mmol/l
4.6
4.7
2.17
3056
33431
(3018405) Lactate [Moles/volume] in Arterial blood
254
1249
2.10
25.77
4.8
3.8
mmol/l
1.5
1.4
0.85
248
1230
(3044290) Cell count panel - Cerebral spinal fluid
180
768
2.40
25.75
2.7
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
43
69
6.28
25.69
1.5
1.2
—
—
—
0
0
(4062490)
108
355
3.09
25.64
1.3
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
179
765
2.40
25.51
3.7
2.9
umol/l
35.4
34.2
0.25
147
658
(40757373) Influenza virus identified in Isolate
44
73
6.08
25.44
1.9
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
181
779
2.38
25.39
2.6
2.2
g/l
118.0
128.3
6.02
150
559
(3052592) Norovirus Ag [Presence] in Stool
37
52
7.17
24.99
1.6
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
99
314
3.20
24.96
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
104
340
3.11
24.93
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
428
2530
1.77
24.92
4.4
2.9
e9/l
3.2
4.1
7.11
356
1970
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
97
306
3.22
24.68
1.2
1.4
u/l
958.2
335.7
0.67
90
297
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
186
821
2.32
24.64
2.2
1.3
mmol/l
3.7
3.8
0.05
179
765
(3024139) IgG subclass 3 [Mass/volume] in Serum
106
355
3.04
24.38
1.3
1.4
g/l
0.4
0.4
0.03
73
245
(3028192) IgG subclass 2 [Mass/volume] in Serum
106
355
3.04
24.38
1.3
1.4
g/l
2.4
2.9
1.96
74
248
(3027135) IgG subclass 1 [Mass/volume] in Serum
106
356
3.03
24.27
1.3
1.4
g/l
7.0
6.8
0.21
73
249
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
31
9
34.67
24.25
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3372
30458
1.47
24.11
46.1
16.8
%
14.4
13.7
103.59
3342
29791
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
543
3461
1.65
23.91
3.4
2.4
u/l
32.3
51.9
0.80
482
2956
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
30
8
37.76
23.91
2.4
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
129
491
2.68
23.44
1.3
1.2
u/l
129.1
37.2
3.67
113
429
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
232
1144
2.09
23.36
1.6
1.6
iu/ml
0.1
6.0
0.60
53
234
(3051651) Icteric interference index of Serum or Plasma
79
227
3.53
23.30
4.7
3.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
124
468
2.70
22.92
1.2
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
114
412
2.81
22.89
1.5
1.4
e6/l
9304.9
2191.1
0.48
93
297
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
69
183
3.81
22.89
1.2
1.1
u/l
33.5
23.3
0.57
50
135
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
69
184
3.79
22.71
1.2
1.1
u/l
96.7
79.5
0.77
55
139
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
67
177
3.83
22.35
2.1
1.3
%
60.9
66.7
0.19
13
20
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
79
235
3.40
22.11
2.3
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
88
282
3.16
21.85
1.6
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
50
109
4.63
21.45
4.9
5.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
151
650
2.37
21.21
1.8
1.5
mmol/l
68.0
63.8
0.56
110
526
(3022313) Gas panel - Capillary blood
312
1761
1.83
21.13
8.6
4.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
113
425
2.70
21.05
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
102
368
2.81
20.58
1.5
1.4
e6/l
46184.4
85797.6
0.70
64
208
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1029
7751
1.43
20.49
1.7
1.7
pmol/l
21191809.7
34341051.3
0.37
873
6453
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
278
1534
1.87
20.23
1.8
1.8
u/l
40.7
38.7
0.72
249
1363
(3044889) 12 lead EKG panel
2885
25696
1.36
19.64
4.7
3.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
225
1173
1.97
19.43
1.9
1.7
titre
722.1
317.4
0.61
12
54
(3009214) Lutropin [Units/volume] in Serum or Plasma
182
880
2.11
19.32
1.6
1.5
u/l
13.1
11.1
0.78
153
709
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
209
1067
2.01
19.16
3.9
2.2
u/l
3741.1
4452.4
0.09
72
421
(3007566) Smooth muscle Ab [Titer] in Serum
198
993
2.04
19.07
1.4
1.2
titre
99.0
89.4
0.16
29
88
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1382
11053
1.37
19.02
2.8
2.1
u/l
170.2
210.9
0.83
1306
10373
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
49
117
4.22
18.78
2.0
1.2
%
26.8
16.5
0.43
13
15
(3019550) Sodium [Moles/volume] in Serum or Plasma
3987
37750
1.65
18.77
37.5
15.8
mmol/l
139.1
139.7
40.62
3931
36800
(4281824)
106
415
2.59
18.28
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
254
1408
1.85
18.22
5.8
4.5
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
22
24
9.21
18.20
1.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
38
76
5.03
18.06
1.2
1.2
—
—
—
0
0
(4212803)
23
27
8.56
18.01
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
279
1600
1.79
17.92
5.9
2.9
%
0.7
0.7
1.18
270
1538
(3023103) Potassium [Moles/volume] in Serum or Plasma
3990
37857
1.63
17.74
38.2
15.9
mmol/l
4.0
4.0
0.55
3933
36838
(3046861) Legionella sp Ag [Presence] in Urine
16
11
14.59
17.61
1.1
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
71
230
3.12
17.38
1.5
1.6
u/l
5.9
5.8
0.02
36
110
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
19
18
10.60
17.32
3.7
4.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
113
472
2.43
17.03
1.7
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
100
396
2.56
16.88
1.9
1.5
mosm/kgh2o
278.4
279.1
0.11
85
299
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
12
13.38
16.79
5.1
3.5
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
16
12
13.38
16.79
5.1
3.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
201
1062
1.94
16.71
5.3
4.0
mmol/l
3.8
3.9
0.19
179
998
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
49
128
3.86
16.68
1.4
1.5
%
63.5
63.8
0.02
42
105
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
21
6
35.15
16.65
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
211
1137
1.90
16.54
2.6
1.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
95
371
2.60
16.50
11.7
5.7
mmol/l
7.8
7.3
0.43
83
315
(3001893) Eosinophils/100 leukocytes in Pleural fluid
44
107
4.14
16.50
1.4
1.5
%
1.7
3.5
1.00
39
93
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
68
222
3.10
16.45
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
343
2151
1.65
15.91
6.5
3.3
g/l
114.5
129.1
25.23
333
2092
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1764
14905
1.31
15.87
2.1
2.0
pmol/l
90.3
96.5
6.49
1063
7526
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
111
476
2.37
15.81
1.1
1.1
g/l
1.6
1.5
2.16
103
428
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
145
695
2.12
15.80
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
98
398
2.50
15.72
2.8
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3227
34602
0.74
15.70
4.0
3.9
mmol/l
1.3
1.3
2.46
2921
31611
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
265
1557
1.75
15.66
9.8
4.6
mmol/l
25.0
24.8
0.68
254
1461
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
252
1461
1.77
15.60
7.8
5.5
%
1.6
1.6
0.13
236
1359
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
906
6957
1.38
15.54
3.7
3.6
ng/l
500.5
551.8
0.09
718
5322
(3020393) Adenovirus Ag [Presence] in Stool
29
52
5.61
15.53
2.3
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
67
225
3.01
15.47
1.1
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
37
83
4.49
15.39
1.5
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
67
226
2.99
15.35
1.1
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
26
43
6.08
15.11
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
91
364
2.53
15.08
2.2
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
44
115
3.85
14.99
1.6
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
69
241
2.89
14.87
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
195
1062
1.88
14.82
1.4
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
60
194
3.12
14.79
1.3
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
176
929
1.93
14.71
1.5
1.5
iu/ml
8.9
16.9
—
5
25
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
36
82
4.42
14.70
1.2
1.2
ug/l
346.5
412.5
0.06
20
40
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3117
33512
0.76
14.68
5.4
5.7
mmol/mol
39.3
39.6
1.10
2865
30957
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
122
565
2.19
14.53
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
195
1072
1.86
14.40
1.4
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
246
1451
1.74
14.35
7.9
5.5
%
0.9
0.9
0.46
230
1354
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
837
6418
1.38
14.35
1.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
196
1081
1.85
14.32
1.4
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
37
88
4.23
14.31
1.1
1.5
g/l
12.0
13.6
0.45
27
70
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2661
23921
1.29
14.15
4.7
3.1
u/l
70.5
47.3
12.74
2517
22230
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
309
1947
1.63
14.06
12.3
10.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
214
1221
1.79
14.01
2.7
2.2
ug/l
603.6
635.5
0.03
201
1145
(3036782) Glucose [Moles/volume] in Pleural fluid
83
332
2.53
13.79
1.3
1.4
mmol/l
5.9
6.5
1.08
77
315
(40761539) Cells [Type] in Urine sediment by Light microscopy
36
87
4.16
13.65
1.3
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
201
1135
1.81
13.62
8.7
6.6
mmol/l
1.4
1.3
0.61
178
994
(3023323) Follitropin [Units/volume] in Serum or Plasma
259
1577
1.68
13.46
1.6
1.4
iu/l
30.9
30.2
0.10
223
1340
(3051611) Lipemic interference index of Serum or Plasma
91
385
2.39
13.42
4.5
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
569
4130
1.43
13.35
1.4
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
30
64
4.71
13.28
5.1
5.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
168
906
1.89
13.19
1.7
1.5
pmol/l
265.1
178.8
0.76
163
888
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
119
568
2.13
13.16
1.3
1.4
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
20
29
6.92
13.13
1.3
1.2
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
19
26
7.33
13.11
1.5
1.5
mg/l
1.2
0.9
0.19
12
17
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
19
26
7.33
13.11
1.5
1.5
mg/l
2.9
4.9
0.41
13
14
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
19
26
7.33
13.11
1.5
1.5
mg/l
0.3
1.2
0.63
11
14
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
19
26
7.33
13.11
1.5
1.5
mg/l
0.5
0.7
0.19
11
14
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
19
26
7.33
13.11
1.5
1.5
mg/l
1.5
1.2
—
9
14
(3037121) Protein [Mass/volume] in Urine
214
1257
1.74
12.69
5.2
3.2
g/l
0.4
0.3
0.29
142
504
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
19
27
7.06
12.69
1.5
1.6
mg/l
1.1
1.7
0.17
12
16
(3013512) EKG study
1286
10654
1.29
12.68
4.3
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
181
3095
0.57
12.62
1.2
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
54
181
3.01
12.57
2.3
2.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
240
1461
1.68
12.50
1.3
1.3
u/ml
0.7
1.3
0.83
11
131
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
134
682
2.00
12.49
4.3
2.9
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
64
238
2.71
12.34
2.1
1.4
mmol/l
32.7
33.9
0.18
56
210
(3019977) pH of Arterial blood
53
178
3.00
12.30
2.7
2.8
ph
7.4
7.4
0.21
17
59
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
81
340
2.41
12.19
1.8
1.5
ug/l
2.5
4.3
1.11
58
289
(3033799) Differential panel - Peritoneal fluid
38
104
3.68
12.18
1.4
2.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
16
6
26.75
12.03
1.1
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
24
46
5.24
12.00
1.0
1.0
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
39
110
3.57
11.97
1.3
2.1
e6/l
17306.5
19777.1
0.04
27
60
(3023487) Leukocytes [#/volume] in Peritoneal fluid
42
125
3.38
11.89
1.5
2.3
e6/l
508.0
776.7
0.82
33
91
(3026389) Candida sp identified in Specimen by Organism specific culture
109
526
2.10
11.76
1.4
1.4
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
12
10
12.03
11.74
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
514
3746
1.42
11.73
8.6
4.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
79
335
2.38
11.64
1.5
1.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
31
76
4.10
11.57
6.6
3.0
u/l
80.9
43.3
0.60
14
24
(3019832) Treponema pallidum Ab [Presence] in Serum
397
2767
1.48
11.48
1.6
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
17
24
7.11
11.41
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
175
1002
1.78
11.37
1.2
1.3
miu/ml
172.3
217.9
0.80
50
467
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
70
286
2.47
11.20
1.4
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
185
3041
0.59
11.09
1.6
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
44
143
3.10
10.84
1.8
1.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
110
553
2.01
10.67
1.3
1.2
u/ml
3.7
4.8
0.61
54
224
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
406
2886
1.45
10.60
5.0
3.9
ng/l
96.3
86.8
1.07
363
2482
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
112
569
1.99
10.55
1.3
1.2
u/ml
1.7
4.6
2.35
50
183
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
53
195
2.74
10.48
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
282
1882
1.53
10.05
11.3
9.8
mmol/l
24.8
24.3
1.89
269
1763
(3022217) INR in Platelet poor plasma by Coagulation assay
598
4590
1.35
9.90
16.5
24.2
inr
1.3
1.3
0.19
101
678
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
46
163
2.84
9.78
1.2
1.1
u/ml
11.9
31.2
—
8
15
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
79
364
2.19
9.66
1.1
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
11
10.02
9.54
2.3
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
332
2322
1.47
9.43
3.6
3.3
pmol/l
4.5
4.5
0.07
288
2057
(3032057) Clostridioides difficile [Presence] in Stool
29
79
3.69
9.41
1.9
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
662
5196
1.32
9.39
1.3
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
63
267
2.38
9.37
1.2
1.2
titre
325.5
157.7
0.55
11
56
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3620
34444
1.30
9.30
33.6
12.8
ml/min/173m2
82.2
81.0
2.85
3282
28361
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
114
2033
0.55
9.24
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
203
2.58
9.21
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
131
737
1.80
9.10
1.9
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
180
1108
1.65
9.06
1.3
1.4
ug/g
259.4
279.3
0.68
119
631
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
15
24
6.27
8.98
1.5
2.0
%
61.0
55.4
—
9
17
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
52
207
2.53
8.86
1.2
1.1
ratio
1.1
1.0
0.58
26
75
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
84
412
2.06
8.78
1.2
1.1
—
2.5
—
0
6
(3042010) Triglyceride [Moles/volume] in Pleural fluid
23
56
4.12
8.70
1.1
1.2
mmol/l
3.9
1.8
0.40
18
42
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
405
2985
1.39
8.62
3.1
2.9
ng/l
202.9
184.7
0.32
365
2728
(3044007) Cell count panel - Peritoneal fluid
32
100
3.22
8.47
1.4
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
45
171
2.65
8.43
1.6
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
98
522
1.90
8.14
1.1
1.1
%
120.5
117.2
0.37
89
470
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
10
11
9.11
8.08
1.2
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
137
812
1.71
7.99
11.2
7.6
mmol/l
10.9
11.3
0.51
124
722
(40763480) Human metapneumovirus Ag [Presence] in Specimen
12
17
7.07
7.99
2.2
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
17
7.07
7.99
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
80
400
2.02
7.98
3.9
2.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
137
813
1.71
7.96
11.2
7.6
mmol/l
105.3
105.2
0.09
124
723
(3043410) Blood group antigens tested for on Red Blood Cells
31
100
3.11
7.81
2.6
1.8
—
—
—
0
0
(4306422)
99
538
1.86
7.75
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
628
7761
0.78
7.69
4.2
4.3
%
21.5
21.7
0.17
306
3822
(40761535) Cells panel - Urine sediment
402
3015
1.37
7.69
4.3
3.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
434
5629
0.75
7.62
2.6
3.1
ug/l
0.8
0.8
0.51
299
3793
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
396
2968
1.37
7.61
5.2
2.6
ml/min/173m2
57.0
65.9
4.65
173
1188
(3013293) Extractable nuclear Ab [Presence] in Serum
21
53
3.98
7.60
1.6
1.5
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
12
8.35
7.58
1.1
1.0
—
—
—
0
0
(3036603) Volume of Urine
53
230
2.32
7.55
1.3
1.4
ml
1988.6
2017.9
0.06
16
43
(3021788) Differential panel - Synovial fluid
113
645
1.77
7.55
1.8
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
54
3.90
7.42
1.8
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
54
3.90
7.42
1.8
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
54
3.90
7.42
1.8
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
42
165
2.56
7.41
4.2
4.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
36
131
2.76
7.37
1.2
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
78
399
1.97
7.33
2.5
1.4
iu/ml
35.0
23.9
—
8
18
(3017569) Oxygen content in Arterial blood
43
172
2.51
7.32
2.5
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
52
228
2.30
7.25
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
139
852
1.65
7.19
1.8
1.6
e6/l
15518.8
12294.3
0.36
108
615
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
152
953
1.62
7.18
1.6
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
100
3.01
7.18
2.5
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
30
100
3.01
7.18
2.5
2.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
33
117
2.83
7.09
3.2
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
89
488
1.84
6.82
1.4
1.4
u/l
32.6
29.3
0.41
79
401
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
129
788
1.66
6.78
1.3
1.2
u/ml
3.2
5.8
0.43
17
59
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
59
281
2.11
6.75
1.2
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
42
173
2.44
6.75
3.1
1.9
umol/l
29.0
29.2
0.03
42
167
(3011325) HIV 1+2 Ab [Presence] in Serum
10
14
7.16
6.69
1.1
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3406
35474
0.82
6.67
4.7
4.6
mmol/l
5.9
5.9
0.57
3128
32331
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4012
39013
1.35
6.67
26.8
10.3
u/l
25.9
25.9
0.01
3960
37595
(3010937) Rubella virus Ab [Presence] in Serum
12
21
5.73
6.58
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
67
339
1.99
6.54
3.2
3.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
117
2.75
6.52
1.2
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
26
85
3.07
6.45
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
26
85
3.07
6.45
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
26
85
3.07
6.45
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
26
85
3.07
6.45
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
81
1431
0.56
6.44
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
95
545
1.76
6.30
1.2
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
38
4.22
6.28
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2942
31002
0.84
6.26
48.7
17.8
g/l
331.2
332.2
6.86
2925
30787
(3017501) Neutrophils [#/volume] in Blood by Manual count
6
0
+∞
6.25
1.7
0.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
155
1012
1.55
6.22
1.1
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
41
177
2.33
5.98
1.4
1.8
u/field
2.2
3.3
0.41
30
124
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
56
275
2.05
5.96
1.4
1.5
umol/l
12.6
12.4
0.07
56
258
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
149
978
1.54
5.86
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
174
1182
1.49
5.83
1.8
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
43
192
2.25
5.82
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
41
180
2.29
5.77
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
70
377
1.87
5.74
4.1
1.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
39
169
2.32
5.66
1.2
1.2
iu/ml
4.0
3.9
—
5
11
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
146
965
1.53
5.58
1.3
1.2
u/ml
6.1
3.0
0.71
30
100
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
146
2.41
5.53
3.6
2.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
25
88
2.85
5.50
1.3
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
35
147
2.39
5.45
1.0
1.1
miu/ml
1080.4
1480.7
1.46
35
147
(4268621)
71
391
1.83
5.45
2.4
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
147
979
1.52
5.43
1.4
1.3
u/ml
21.1
6.3
0.99
39
162
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
38
166
2.30
5.43
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
164
1118
1.48
5.42
1.7
1.6
mu/l
371.5
314.5
0.85
148
1014
(3005322) IgE [Units/volume] in Serum or Plasma
305
2319
1.34
5.38
1.4
1.3
u/ml
249.2
201.4
0.31
265
2135
(3020717) Zinc [Moles/volume] in Serum or Plasma
43
199
2.17
5.36
1.7
1.4
umol/l
22.5
23.6
0.09
43
187
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
42
193
2.19
5.33
1.5
1.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
118
752
1.58
5.31
5.0
3.0
mmol/l
1.5
1.5
0.18
118
730
(3002331) Protein [Mass/volume] in Peritoneal fluid
23
79
2.92
5.29
1.2
1.5
g/l
20.3
25.6
0.85
17
60
(1761868) Lipid panel - Serum or Plasma
1118
12605
0.85
5.24
2.8
2.8
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
47
229
2.06
5.16
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
900
7799
1.19
5.12
5.4
4.1
kg/l
1.0
1.0
0.01
139
1146
(3051387) C reactive protein [Mass/volume] in Capillary blood
123
799
1.55
5.11
4.0
3.5
mg/l
33.7
25.8
1.50
90
494
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
44
210
2.11
5.10
1.4
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
310
2385
1.32
5.06
3.5
3.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
27
4.45
5.03
5.3
7.3
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
27
4.45
5.03
1.5
1.2
ml/s/173m2
1.6
0.9
—
7
20
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
47
232
2.04
4.99
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
246
1832
1.36
4.99
1.5
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
41
192
2.15
4.99
2.3
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
76
440
1.74
4.97
1.9
1.6
%
58.8
60.0
0.11
52
272
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
77
2.87
4.91
4.9
2.4
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
153
1051
1.47
4.90
1.3
1.2
u/ml
16.4
40.2
1.36
16
62
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
953
8330
1.18
4.89
1.3
1.3
u/ml
1.0
1.6
2.07
250
2142
(3018291) Platelet Ab [Presence] in Serum
8
7
11.45
4.78
1.3
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
7
11.45
4.78
6.3
6.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
974
8545
1.18
4.77
4.6
3.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
38
176
2.17
4.77
1.9
2.3
mmol/l
8.2
9.5
1.40
30
141
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
378
3026
1.27
4.59
2.2
2.3
ug/l
7.7
7.0
0.26
319
2669
(3030313) Adrenal Ab [Titer] in Serum
11
25
4.41
4.56
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
544
4550
1.22
4.46
2.9
2.3
ug/g
213.9
133.0
1.19
448
3581
(3045414) Leukocytes [Presence] in Urine
223
1668
1.35
4.44
2.4
1.9
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
30
4.01
4.43
2.0
2.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
68
397
1.72
4.36
1.2
1.1
%
89.4
95.3
0.91
62
375
(3039162) Centromere protein B Ab [Units/volume] in Serum
78
475
1.65
4.29
1.3
1.3
u/ml
53.4
41.8
—
10
29
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
24
95
2.53
4.29
1.8
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
30
132
2.28
4.28
1.1
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
8
9
8.90
4.27
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
12
31
3.88
4.25
1.3
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
17
56
3.04
4.23
1.9
1.5
ng/l
151.6
106.9
0.55
17
56
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
46
3.27
4.18
1.7
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
32
147
2.19
4.14
1.1
1.1
ng/l
2730.7
389.5
—
9
36
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
320
3990
0.79
4.13
1.7
1.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
12
32
3.76
4.08
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
52
3.08
4.08
1.7
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
15
48
3.13
3.92
13.3
10.1
mmol/l
5.0
6.0
0.83
15
48
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
58
336
1.74
3.87
1.8
1.5
%
36.9
32.7
0.33
43
201
(3038026) Centromere Ab [Units/volume] in Serum
53
300
1.78
3.83
1.2
1.2
u/ml
43.4
51.3
—
7
17
(3004451) EKG impression Narrative
35
173
2.03
3.78
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
26
114
2.29
3.77
1.3
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
104
701
1.50
3.75
5.5
3.1
mmol/l
7.2
7.4
0.22
104
682
(4027681)
39
202
1.94
3.71
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
886
9942
0.86
3.70
1.8
1.6
mmol/l
1.5
1.4
1.23
738
8355
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
10
25
4.01
3.69
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2426
22969
1.13
3.68
3.4
2.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
47
260
1.82
3.67
1.1
1.1
mg/l
474.8
264.1
0.64
39
227
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
51
290
1.77
3.64
1.2
1.2
u/ml
79.1
56.6
—
7
14
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
22
91
2.42
3.63
3.0
1.7
ug/l
2.7
1.9
0.73
16
46
(3004616) Nuclear Ab [Presence] in Serum
73
458
1.60
3.63
1.3
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
98
2.35
3.57
1.0
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
50
285
1.76
3.55
1.1
1.0
mg/l
336.1
290.2
1.50
45
257
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
51
293
1.75
3.53
1.2
1.2
u/ml
28.1
44.1
—
7
26
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
30
144
2.09
3.52
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
90
1328
0.67
3.50
1.9
1.7
mg/l
10.1
3.6
1.32
71
940
(3045424) Erythrocytes [Presence] in Urine
94
632
1.50
3.46
1.8
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
100
2.31
3.42
1.7
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
57
342
1.68
3.39
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
35
181
1.94
3.37
2.1
1.7
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
18
5.01
3.37
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
47
268
1.76
3.35
2.3
2.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
27
3.71
3.35
1.0
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
47
269
1.76
3.31
1.1
1.2
mg/l
107.6
39.2
0.68
33
225
(1761482) Bacteria [#/volume] in Urine by Culture
123
880
1.41
3.29
5.3
4.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
141
1034
1.38
3.27
1.1
1.1
u/ml
4.9
6.0
0.14
13
126
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
122
2.14
3.25
1.0
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
9
19
4.74
3.23
3.0
1.9
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
116
2.16
3.21
1.2
1.1
%
87.6
92.6
0.35
13
58
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
28
3.58
3.19
1.1
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
7
11
6.37
3.18
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
48
281
1.72
3.15
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
48
281
1.72
3.15
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
48
282
1.71
3.11
1.4
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
9
20
4.51
3.11
3.0
1.8
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
54
328
1.65
3.10
1.4
1.4
e6/l
23746.7
85737.6
1.02
41
226
(3050129) First trimester maternal screen panel - Serum or Plasma
48
789
0.60
3.09
1.4
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
48
283
1.70
3.08
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
48
283
1.70
3.08
1.4
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
8
16
5.01
3.05
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
10
29
3.45
3.04
13.9
4.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
48
284
1.70
3.04
1.4
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
62
2.59
3.04
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
229
1821
1.27
3.03
5.0
3.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
47
277
1.70
3.02
1.3
1.2
u/ml
20.6
3.6
—
8
20
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
41
696
0.59
3.00
1.4
1.5
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
24
113
2.13
2.99
1.2
1.3
%
76.8
90.2
0.96
12
56
(3001019) Free T4 and TSH panel - Serum or Plasma
138
1836
0.74
2.98
1.6
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3889
38135
1.18
2.95
31.4
13.0
—
—
—
0
0
(3001729) Color of Synovial fluid
10
30
3.34
2.90
1.1
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1025
11228
0.89
2.90
4.3
4.0
mg/mmol
12.0
8.9
1.14
611
6987
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
22
4.10
2.88
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
15
58
2.59
2.87
2.3
2.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
13
47
2.77
2.81
1.4
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
23
110
2.10
2.78
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
10
31
3.23
2.77
1.4
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2970
28666
1.11
2.75
4.7
4.1
pmol/l
14.8
14.8
0.21
2749
26061
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
22
104
2.12
2.74
1.1
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
20
91
2.20
2.73
3.0
3.4
ng/l
132.3
148.6
0.10
13
45
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
719
6419
1.14
2.72
1.3
1.3
iu/ml
43.2
32.4
0.83
228
1985
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
43
2.80
2.64
1.1
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
37
213
1.74
2.62
2.2
2.1
min
535.5
489.8
2.04
24
157
(3003740) Influenza virus B Ag [Presence] in Specimen
77
530
1.46
2.61
1.3
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
100
2.11
2.58
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
13
50
2.60
2.53
1.1
1.2
%
76.4
52.8
—
7
24
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
33
3.03
2.52
1.1
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
77
536
1.44
2.48
1.1
1.1
u/ml
1.9
3.5
0.98
22
230
(3017446) Testosterone [Moles/volume] in Serum or Plasma
268
2225
1.22
2.46
2.4
2.2
nmol/l
11.3
12.6
1.55
246
1948
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
42
256
1.65
2.44
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
78
547
1.43
2.42
1.0
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
106
784
1.36
2.42
1.3
1.2
u/ml
51.7
41.2
0.33
18
89
(4146454)
22
416
0.53
2.42
2.2
2.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
21
103
2.04
2.41
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
76
532
1.44
2.39
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
37
220
1.69
2.37
2.4
1.5
u/l
8.7
7.0
0.44
26
188
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
8
6.25
2.37
10.6
11.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
111
1.99
2.35
1.1
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
16
71
2.26
2.34
1.3
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
17
78
2.18
2.30
1.3
1.2
%
58.4
80.8
—
5
22
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
90
1220
0.73
2.27
1.5
1.5
—
—
—
0
0
(44806071)
11
41
2.69
2.27
1.2
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
6
13
4.62
2.27
5.0
4.9
umol/l
371.3
366.7
—
6
13
(3032743) Legionella sp IgG Ab [Presence] in Serum
8
23
3.48
2.27
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
23
3.48
2.27
1.3
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
8
23
3.48
2.27
1.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
7
18
3.89
2.25
1.1
1.6
nmol/l
53.3
12.6
—
7
18
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
404
4617
0.86
2.16
4.0
4.5
%
31.0
32.6
2.24
296
3068
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
25
437
0.57
2.14
1.6
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
81
588
1.38
2.11
1.0
1.1
au/ml
9.1
9.9
—
5
28
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
37
2.71
2.10
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
79
572
1.39
2.10
1.5
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
28
160
1.75
2.09
6.4
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
23
125
1.84
2.02
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
39
600
0.65
2.00
1.2
1.1
u/ml
0.6
1.3
0.80
23
273
(3012898) Urea [Moles/volume] in Urine
9
32
2.82
2.00
1.1
1.3
mmol/l
134.7
178.0
—
9
27
(3022475) Manganese [Moles/volume] in Blood
7
21
3.34
1.96
1.4
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
121
946
1.29
1.94
1.9
1.8
iu/l
4.0
4.6
0.40
53
324
(40768443) Skin Pathology biopsy report
195
1611
1.22
1.94
1.2
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
5
11
4.55
1.94
5.2
3.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
112
868
1.30
1.92
3.0
2.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
43
642
0.67
1.92
1.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
74
539
1.38
1.92
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
39
2.57
1.92
1.1
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
42
274
1.54
1.91
1.2
1.3
mmol/l
10.5
12.4
0.99
14
75
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
43
641
0.67
1.91
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
135
1.78
1.90
3.0
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
34
532
0.64
1.90
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
43
640
0.67
1.90
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
43
639
0.67
1.88
1.3
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
25
143
1.75
1.88
1.9
2.0
ug/l
17.0
238.7
0.70
25
128
(4094501)
74
998
0.74
1.87
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
34
529
0.64
1.86
1.4
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
72
2.09
1.86
1.4
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
46
2.39
1.85
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
42
277
1.52
1.84
2.2
2.2
ml
847.3
633.6
2.24
27
186
(3036525) Urea [Moles/time] in 24 hour Urine
6
17
3.53
1.83
3.5
3.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
31
190
1.64
1.83
1.4
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
34
526
0.64
1.82
1.3
1.6
—
—
—
0
0
(4010399)
226
2664
0.84
1.81
1.5
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
35
2.57
1.80
1.3
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
996
10675
0.91
1.77
3.5
3.3
mg/l
1243.3
314.3
3.00
619
6611
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
39
582
0.67
1.76
1.3
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
14
67
2.09
1.75
3.4
2.0
umol/l
18.5
18.0
0.06
14
67
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
38
248
1.54
1.75
1.0
1.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
16
81
1.98
1.74
1.4
1.3
%
96.9
110.7
0.69
16
76
(3043238) Trisomy 21 risk [Likelihood] in Fetus
36
544
0.66
1.74
1.4
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
34
519
0.65
1.72
2.0
1.7
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
29
178
1.63
1.72
1.9
1.4
%
4.0
3.7
0.07
14
35
(3042517) Benzodiazepines panel - Urine
7
24
2.92
1.72
4.0
2.3
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
13
3.85
1.71
1.4
1.1
nmol/l
382.6
282.2
—
5
13
(3044927) Protein electrophoresis panel - Urine
52
365
1.43
1.70
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
25
148
1.69
1.70
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
162
0.43
1.66
1.1
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
85
650
1.31
1.65
1.4
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
43
620
0.69
1.65
1.2
1.1
u/ml
3.4
4.8
0.43
29
329
(3024928) Oxygen saturation in Venous blood
98
765
1.29
1.64
10.4
3.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
86
660
1.31
1.63
3.2
3.1
nmol/l
0.9
0.8
0.54
59
501
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
24
143
1.68
1.60
2.1
2.8
ug/l
1.5
1.5
0.01
24
133
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
43
2.33
1.60
1.1
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
10
43
2.33
1.60
11.4
10.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
32
2.50
1.59
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
907
9715
0.92
1.59
5.0
5.0
ug/l
4.7
2.8
1.91
793
8682
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
218
0.50
1.50
1.2
1.4
—
1.5
—
0
13
(4198724)
23
139
1.66
1.48
1.4
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
37
2.44
1.47
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
25
390
0.64
1.44
1.2
1.1
u/ml
0.0
0.5
—
6
104
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
22
2.73
1.43
1.5
5.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
40
2.25
1.40
2.1
2.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
40
2.25
1.40
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
134
1.64
1.38
1.2
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
13
67
1.94
1.38
4.9
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
13
67
1.94
1.38
2.5
2.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
31
206
1.51
1.37
2.8
2.4
umol/l
86.8
32.3
—
7
17
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
41
2.20
1.37
1.2
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
662
6127
1.09
1.36
1.3
1.2
u/ml
23.9
12.1
2.10
223
2365
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
39
0.00
1.33
0.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
39
274
1.43
1.32
1.6
2.0
u/field
1.5
1.9
0.46
20
107
(3011985) Renin [Units/volume] in Plasma
65
498
1.31
1.30
1.8
1.4
mu/l
88.5
67.5
0.17
60
440
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
43
2.10
1.30
2.1
2.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
456
4158
1.11
1.28
2.0
1.7
%
1.5
1.5
0.83
389
3670
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
13
69
1.89
1.28
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
156
1324
1.18
1.26
2.6
2.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
366
3302
1.12
1.25
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
52
688
0.75
1.25
1.2
1.1
u/ml
3.5
1.8
0.29
29
289
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
6
25
2.40
1.24
1.0
1.1
—
22.3
—
0
7
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
19
2.63
1.21
1.6
3.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
33
229
1.44
1.21
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
93
1.72
1.21
1.1
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
71
1.83
1.19
1.3
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
13
71
1.83
1.19
1.2
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
41
298
1.38
1.18
1.1
1.2
nmol/l
323.7
376.4
0.74
35
259
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
19
117
1.63
1.17
4.4
2.8
umol/l
24.9
29.2
1.05
13
83
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
60
464
1.30
1.16
1.4
1.3
pmol/l
579.8
367.4
0.37
40
363
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
20
2.50
1.15
1.2
1.5
umol/24h
598.0
368.7
—
5
20
(3028707) Methadone [Presence] in Urine by Screen method
69
544
1.27
1.15
6.6
2.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
95
1.69
1.13
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
48
362
1.33
1.11
3.3
4.6
u/ml
103.5
84.9
—
9
96
(3014271) Vancomycin [Susceptibility]
26
176
1.48
1.10
2.6
2.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
32
2.19
1.08
1.3
1.9
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
52
1.93
1.06
1.1
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
663
6211
1.08
1.05
1.5
1.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
34
245
1.39
1.05
1.1
1.1
iu/ml
10.1
11.1
—
10
63
(3045462) Protein/Creatinine [Ratio] in Urine
9
46
1.96
1.03
8.6
4.5
g/mol
40.0
56.2
—
9
40
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
34
2.06
1.02
1.0
1.2
u/l
4.6
12.4
—
7
34
(40768800) Prostate Pathology biopsy report
47
610
0.77
1.02
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
42
315
1.34
1.02
1.2
1.3
nmol/l
1.5
1.5
0.14
37
284
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
151
0.53
1.02
1.4
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1095
11455
0.94
1.00
3.8
3.2
mmol/l
6.8
7.4
4.44
928
9629
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
164
1.47
0.99
2.7
2.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
29
0.00
0.97
0.0
1.0
—
1.2
—
0
17
(4034850)
101
1194
0.84
0.95
12.0
9.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
426
4602
0.92
0.95
15.2
6.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
51
1.77
0.94
1.1
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
146
0.55
0.92
2.8
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
55
1.82
0.92
2.1
3.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
55
1.82
0.92
1.2
1.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
26
184
1.42
0.91
1.1
1.2
u/l
435.2
297.8
0.18
21
170
(3020650) Glucose [Presence] in Urine
15
94
1.60
0.90
1.1
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
53
421
1.26
0.88
1.4
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
13
79
1.65
0.88
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
68
557
1.22
0.87
1.4
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
39
301
1.30
0.82
16.1
4.0
%
9.0
11.2
3.23
39
301
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
32
1.88
0.81
1.2
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
276
2525
1.10
0.80
1.2
1.2
iu/ml
107.6
148.3
1.41
87
940
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
107
1235
0.86
0.79
1.5
1.5
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
10.7
—
0
20
(3016031) Almond IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
2.3
—
0
16
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
28
209
1.34
0.75
1.1
1.1
u/l
1.3
1.1
0.80
13
110
(3013139) Helicobacter pylori Ag [Presence] in Stool
234
2563
0.91
0.75
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
36
459
0.78
0.74
1.2
1.1
u/ml
10.0
3.9
0.38
13
175
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
54
1.67
0.74
1.2
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
38
1.84
0.73
1.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
13
84
1.55
0.71
1.2
1.1
umol/24h
0.7
0.7
—
6
44
(3045683) HLA typing for celiac disease panel - Blood or Tissue
30
229
1.31
0.71
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
15
101
1.49
0.70
2.8
1.9
mmol/l
0.8
1.3
0.13
15
93
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
5
27
1.85
0.68
1.2
1.1
—
38.9
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
173
1910
0.90
0.67
1.7
1.9
—
—
—
0
0
(44806420)
5
92
0.54
0.67
1.6
2.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
216
1979
1.10
0.65
2.4
2.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
20
147
1.36
0.61
1.6
2.3
umol/l
260.2
148.0
0.28
11
84
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
15
210
0.71
0.60
1.4
1.4
pmol/l
3801.9
206.4
—
7
66
(3023430) Cat dander IgE Ab [Units/volume] in Serum
34
422
0.80
0.59
1.1
1.1
u/ml
2.3
5.3
1.27
17
172
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
186
0.70
0.59
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
323
3024
1.07
0.59
1.2
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(4015189)
14
97
1.44
0.59
2.1
2.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
50
595
0.84
0.58
1.1
1.1
iu/ml
19.6
1005.2
—
8
136
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
148
1340
1.11
0.58
1.5
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
20
265
0.75
0.58
1.1
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
106
1.42
0.57
1.3
1.4
%
26.5
31.2
—
10
69
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
30
238
1.26
0.56
4.5
6.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
37
1.62
0.55
1.0
1.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
15
107
1.40
0.55
1.4
1.6
ug/l
0.4
0.4
—
10
69
(44813793)
19
249
0.76
0.52
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
47
555
0.85
0.52
1.1
1.1
u/ml
5.4
2.9
—
10
137
(3015183) Erythrocyte sedimentation rate
13
178
0.73
0.48
1.0
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
17
223
0.76
0.48
1.6
2.1
ug/l
2.8
2.3
0.31
12
190
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
68
1.47
0.47
2.3
2.8
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
7
48
1.46
0.46
1.9
1.4
ug/l
88.7
125.8
—
7
42
(3034274) Bile acid [Moles/volume] in Serum --fasting
44
375
1.17
0.45
2.5
2.3
umol/l
20.4
8.7
1.06
31
264
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
50
1.40
0.45
1.0
1.9
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
68
600
1.14
0.44
1.2
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
51
1.37
0.44
1.3
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
16
208
0.77
0.43
1.2
1.1
u/ml
0.9
2.0
—
7
67
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
32
1.56
0.42
1.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
57
1.40
0.42
1.1
1.6
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
102
929
1.10
0.40
5.0
2.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
34
1.47
0.40
1.4
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
66
1.36
0.38
1.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
89
1.35
0.37
7.4
7.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
30
252
1.19
0.37
1.8
2.0
mmol/l
7.2
6.8
0.28
24
165
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
40
345
1.16
0.37
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
115
0.70
0.37
1.0
1.5
ug/l
8.8
8.9
—
8
115
(3000492) Spirometry study
328
3431
0.95
0.36
1.7
1.5
—
—
—
0
0
(4211845)
23
189
1.22
0.36
3.6
3.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
43
1.40
0.35
1.3
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
44
1.36
0.34
1.0
1.1
umol/24h
1.5
1.7
—
6
44
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
46
1.30
0.33
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
21
173
1.21
0.32
3.3
3.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
47
1.28
0.32
1.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
74
1.35
0.32
1.0
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
51
456
1.12
0.31
2.5
2.1
mg/l
34.5
22.0
0.47
14
119
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
142
1511
0.94
0.30
1.6
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
26
222
1.17
0.29
1.3
1.4
—
68.6
—
0
21
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
334
3466
0.96
0.29
1.9
2.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
13
103
1.26
0.28
1.4
1.2
g/l
41.1
38.1
—
8
52
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
91
844
1.08
0.28
2.8
2.4
ug/min
183.2
94.3
0.98
44
518
(3037556) Urate [Mass/volume] in Serum or Plasma
9
119
0.76
0.27
1.4
1.3
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
74
1.22
0.25
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
170
0.82
0.25
7.6
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
81
0.74
0.24
1.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
53
484
1.10
0.24
1.7
1.3
nmol/l
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
13
106
1.23
0.23
1.2
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
16
134
1.19
0.22
1.7
1.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
66
612
1.08
0.22
1.9
1.6
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.4
—
2.1
—
0
10
(3022670) pH of Venous cord blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
17
198
0.86
0.20
1.2
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
128
1220
1.05
0.20
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
145
1387
1.05
0.20
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3351
33366
1.02
0.19
36.2
14.9
%
37.1
39.6
44.55
2236
23961
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
16
186
0.86
0.19
1.3
1.6
mmol/l
7.6
7.9
—
10
114
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
14
118
1.19
0.19
2.2
2.4
mg/l
11.2
9.9
0.50
14
98
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
81
1.23
0.18
5.7
7.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
302
3104
0.97
0.18
1.7
1.9
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
16
185
0.86
0.18
2.3
2.1
ug/min
25.0
157.1
—
5
44
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
22
195
1.13
0.17
1.4
1.3
mmol/l
7.2
5.9
0.81
22
185
(42870560) Thyrotropin [Units/volume] in Cord blood
8
72
1.11
0.16
1.0
1.0
mu/l
7.5
8.2
—
8
64
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
119
0.84
0.15
1.0
1.3
nmol/l
19.4
31.8
—
10
96
(4133840)
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
231
2371
0.97
0.14
1.3
1.3
au/ml
15.3
47.6
—
5
104
(3016879) Cocaine [Presence] in Urine
114
1099
1.04
0.13
4.7
2.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
4071
40766
0.98
0.12
56.6
20.5
g/l
123.8
134.9
307.65
4039
40197
(3010813) Leukocytes [#/volume] in Blood
4071
40764
0.98
0.12
56.4
20.4
e9/l
5.7
6.7
48.34
4005
39585
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3382
33898
0.99
0.10
5.4
4.9
mu/l
2.8
2.1
0.45
3145
31036
(3026361) Erythrocytes [#/volume] in Blood
4071
40756
0.98
0.10
56.3
20.4
e12/l
4.1
4.5
282.91
4004
39581
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
48
504
0.95
0.10
1.8
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
4071
40752
0.98
0.09
56.0
20.3
pg
30.5
30.3
8.35
4042
40177
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
53
553
0.96
0.09
1.6
1.3
nmol/l
0.2
0.3
—
6
31
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
55
1.09
0.08
5.5
8.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
122
1190
1.03
0.08
4.5
2.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
4071
40749
0.98
0.08
56.1
20.3
fl
91.9
91.0
27.76
4041
40178
(3051101) Glucose [Moles/volume] in Cord blood
5
62
0.81
0.08
3.0
6.7
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
63
0.79
0.08
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
5
63
0.79
0.08
1.0
1.0
—
-2.7
—
0
20
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
5
63
0.79
0.08
1.0
1.0
kpa
8.2
7.4
—
5
54
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
67
1.04
0.08
2.9
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
36
343
1.05
0.07
4.2
3.1
mg/l
88.1
35.2
0.48
28
259
(3041806) Other cells [#/volume] in Blood by Manual count
9
86
1.05
0.07
1.3
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4070
40732
0.99
0.06
56.4
20.4
e9/l
222.1
253.1
115.71
4010
39682
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
199
1961
1.02
0.06
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
15
162
0.93
0.06
12.3
12.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
120
1177
1.02
0.06
4.5
2.1
—
—
—
0
0
(4024509)
39
375
1.04
0.05
1.8
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
20
189
1.06
0.04
1.2
1.2
nmol/l
119.5
133.0
0.96
20
189
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
746
0.98
0.04
4.2
2.0
nmol/l
1.3
0.8
2.00
62
619
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
38
368
1.03
0.04
1.5
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
26
271
0.96
0.04
2.8
1.5
g/l
0.9
1.0
0.26
26
271
(3027008) Opiates [Presence] in Urine
120
1185
1.01
0.03
4.5
2.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
262
2603
1.01
0.02
2.3
2.4
au/ml
25.7
22.2
—
7
146
(3027944) Amphetamines [Presence] in Urine
115
1162
0.99
0.02
4.3
2.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
20
208
0.96
0.02
1.2
1.1
u/ml
3.3
2.7
—
10
78
(3025130) Human papilloma virus identified in Specimen
50
491
1.02
0.02
2.0
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
36
366
0.98
0.00
1.8
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
255
0.98
0.00
1.8
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
260
1.00
0.00
1.2
1.3
u/ml
0.1
1.0
—
6
117
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
117
1170
1.00
0.00
1.8
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
81
805
1.01
0.00
4.8
3.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
102
0.98
0.00
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
115
0.96
0.00
2.3
1.5
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
66
0.91
0.00
1.7
1.1
u/ml
0.1
15.9
—
6
46
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
0.2
—
0
5
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
54
0.93
0.00
1.2
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1308.0
—
0
5
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_AGRANULOCYTOSIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AGRANULOCYTOSIS | 5.186 [4.61, 5.84] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.119 |
During the follow-up period (1.1.1998 — 31.12.2019), 4363 out of 13068 females with D3_AGRANULOCYTOSIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_AGRANULOCYTOSIS | 6.042 [5.14, 7.11] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 3667 out of 8454 males with D3_AGRANULOCYTOSIS died.
Mortality risk
Mortality risk for people of age
years, who have D3_AGRANULOCYTOSIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.429% | 1.494% |
| 5 | 2.62% | 7.069% |
| 10 | 6.879% | 16.013% |
| 15 | 13.128% | 28.591% |
| 20 | 21.795% | 45.238% |
Relationships between endpoints
↥Index endpoint: D3_AGRANULOCYTOSIS – Agranulocytosis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data